[Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database]

Objective: To report the long-term outcomes of Chinese rectal cancer patients after adopting a Watch and Wait (W&W) strategy following neoadjuvant therapy (NAT). Methods: This multicenter, cross-sectional study was based on real-world data. The study cohort comprised rectal cancer patients who had achieved complete or near complete clinical responses (cCRs, near-cCRs) after NAT and were thereafter managed by a W&W approach, as well as a few patients who had achieved good responses after NAT and had then undergone local excision for confirmation of pathological complete response. All participants had been followed up for ≥2 years. Patients with distant metastases at baseline or who opted for observation while living with the tumor were excluded. Data of eligible patients were retrospectively collected from the Chinese Wait-and-Watch Data Collaboration Group database. These included baseline characteristics, type of NAT, pre-treatment imaging results, evaluation of post-NAT efficacy, salvage measures, and treatment outcomes. We herein report the long-term outcomes of Chinese rectal cancer patients after NAT and W&W and the differences between the cCR and near-cCR groups. Results: Clinical data of 318 rectal cancer patients who had undergone W&W for over 2 years and been followed up were collected from eight medical centers (Peking University Cancer Hospital, Fudan University Shanghai Cancer Center, Sun Yat-sen University Cancer Center, Shanghai Changhai Hospital, Peking Union Medical College Hospital, Liaoning Cancer Hospital, the First Hospital of Jilin University, and Yunnan Cancer Hospital.) The participants comprised 221 men (69.4%) and 107 women (30.6%) of median age 60 (26-86) years. The median distance between tumor and anal verge was 3.4 (0-10.4) cm. Of these patients, 291 and 27 had achieved cCR or near-cCR, respectively, after NAT. The median duration of follow-up was 48.4 (10.2-110.3) months. The 5-year cumulative overall survival rate was 92.4% (95%CI: 86.8%-95.7%), 5-year cumulative disease-specific survival (CSS) rate 96.6% (95%CI: 92.2%-98.5%), 5-year cumulative organ-preserving disease-free survival rate 86.6% (95%CI: 81.0%-90.7%), and 5-year organ preservation rate 85.3% (95%CI: 80.3%-89.1%). The overall 5-year local recurrence and distant metastasis rates were 18.5% (95%CI: 14.9%-20.8%) and 8.2% (95%CI: 5.4%-12.5%), respectively. Most local recurrences (82.1%, 46/56) occurred within 2 years, and 91.0% (51/56) occurred within 3 years, the median time to recurrence being 11.7 (2.5-66.6) months. Most (91.1%, 51/56) local recurrences occurred within the intestinal lumen. Distant metastases developed in 23 patients; 60.9% (14/23) occurred within 2 years and 73.9% (17/23) within 3 years, the median time to distant metastasis being 21.9 (2.6-90.3) months. Common sites included lung (15/23, 65.2%), liver (6/23, 26.1%), and bone (7/23, 30.4%) The metastases involved single organs in 17 patients and multiple organs in six. There were no significant differences in overall, cumulative disease-specific, or organ-preserving disease-free survival or rate of metastases between the two groups (all P>0.05). The 5-year local recurrence rate was higher in the near-cCR than in the cCR group (41.6% vs. 16.4%, P<0.01), with a lower organ preservation rate (69.2% vs. 88.0%, P<0.001). The success rates of salvage after local recurrence and distant metastasis were 82.1% (46/56) and 13.0% (3/23), respectively. Conclusion: Rectal cancer patients who achieve cCR or near-cCR after NAT and undergo W&W have favorable oncological outcomes and a high rate of organ preservation. Local recurrence and distant metastasis during W&W follow certain patterns, with a relatively high salvage rate for local recurrence. Our findings highlight the importance of close follow-up and timely intervention during the W&W process.

[Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer]

Objective: To investigate perspectives and changes in treatment selection by Chinese surgeons since introduction of the watch-and-wait approach after neoadjuvant therapy for rectal cancer. Methods: A cross-sectional survey was conducted using a questionnaire distributed through the "Wenjuanxing" online survey platform. The survey focused on the recognition and practices of Chinese surgeons regarding the strategy of watch-and-wait after neoadjuvant therapy for rectal cancer and was disseminated within the China Watch-and-Wait Database (CWWD) WeChat group. This group targets surgeons of deputy chief physician level and above in surgical, radiotherapy, or internal medicine departments of nationally accredited tumor-specialist or comprehensive hospitals (at provincial or municipal levels) who are involved in colorectal cancer diagnosis and treatment. From 13 to 16 December 2023, 321 questionnaires were sent with questionnaire links in the CWWD WeChat group. The questionnaires comprised 32 questions encompassing: (1) basic physician characteristics (including surgical volume); (2) assessment methods and criteria for clinical complete response (cCR); (3) patients eligible for watch-and-wait; (4) neoadjuvant therapies and other measures for achieving cCR; (5) willingness to implement watch-and-wait and factors influencing that willingness; (6) risks and monitoring of watch-and-wait; (7) subsequent treatment and follow-up post watch-and-wait; (8) suggestions for development of the CWWD. Descriptive statistics were employed for data analysis, with intergroup comparisons conducted using the χ2 or Fisher's exact probability tests. Results: The response rate was 31.5%, comprising 101 responses from the 321 individuals in the WeChat group. Respondents comprised 101 physicians from 70 centers across 23 provinces, municipalities, and autonomous regions nationwide, 85.1% (86/101) of whom represented provincial tertiary hospitals. Among the respondents, 87.1% (88/101) had implemented the watch-and-wait strategy. The approval rate (65.6%, 21/32) and proportion of patients often informed (68.8%, 22/32) were both significantly higher for doctors in oncology hospitals than for those in general hospitals (27.7%, 18/65; 32.4%, 22/68) (χ2=12.83, P<0.001; χ2=11.70, P=0.001, respectively). The most used methods for diagnosing cCR were digital rectal examination (90.1%, 91/101), colonoscopy (91.1%, 92/101), and rectal T2-weighted magnetic resonance imaging (86.1%, 87/101). Criteria used to identify cCR comprised absence of a palpable mass on digital rectal examination (87.1%, 88/101), flat white scars or new capillaries on colonoscopy (77.2%, 78/101), absence of evident tumor signals on rectal T2-weighted sequences or T2WI low signals or signals equivalent to the intestinal wall (83.2%, 84/101), and absence of tumor hyperintensity on diffusion-weighted imaging with no corresponding hypointensity on apparent diffusion coefficient maps (66.3%, 67/101). As for selection of neoadjuvant regimen and assessment of cCR, 57.4% (58/101) of physicians preferred a long course of radiotherapy with or without induction and/or consolidation capecitabine + oxaliplatin, whereas 25.7% (26/101) preferred immunotherapy in combination with chemotherapy and concurrent radiotherapy. Most (96.0%, 97/101) physicians believed that the primary lesion should be assessed ≤12 weeks after completion of radiotherapy. Patients were frequently informed about the possibility of achieving cCR after neoadjuvant therapy and the strategy of watch-and-wait by 43.6% (44/101) of the responding physicians and 38.6% (39/101) preferred watch-and-wait for patients who achieved cCR or near cCR after neoadjuvant therapy for rectal cancer. Capability for multiple follow-up evaluations (70.3%, 71/101) was a crucial factor influencing physicians' choice of watch-and-wait after cCR. The proportion who patients who did not achieve cCR and underwent surgical treatment was lower in provincial tertiary hospitals (74.2%, 23/31) than in provincial general hospitals (94.5%, 52/55) and municipal hospitals (12/15); these differences are statistically significant (χ2=7.43, P=0.020). The difference between local recurrence and local regrowth was understood by 88.1% (89/101) of respondents and 87.2% (88/101) agreed with monitoring every 3 months for 5 years. An increase in local excision or puncture rates to reduce organ resections in patients with pCR was proposed by 64.4% (65/101) of respondents. Conclusion: Compared with the results of a previous survey, Chinese surgeons' awareness of the watch-and-wait concept has improved significantly. Oncologists in oncology hospitals are more aware of the concept of watch-and-wait.

UiO-66/AgNPs Coating for Dental Implants in Preventing Bacterial Infections

Titanium (Ti)-based biomaterials lack inherent antimicrobial activities, and the dental plaque formed on the implant surface is one of the main risk factors for implant infections. Construction of an antibacterial surface can effectively prevent implant infections and enhance implant success. Silver nanoparticles (AgNPs) exhibit broad antibacterial activity and a low tendency to induce drug resistance, but AgNPs easily self-aggregate in the aqueous environment, which significantly impairs their antibacterial activity. In this study, UiO-66/AgNP (U/A) nanocomposite was prepared, where zirconium metal-organic frameworks (UiO-66) were employed as the confinement matrix to control the particle size and prevent aggregation of AgNPs. The bactericidal activity of U/A against methicillin-resistant Staphylococcus aureus and Escherichia coli increased nearly 75.51 and 484.50 times compared with individually synthesized Ag. The antibacterial mechanism can be attributed to the enhanced membrane rupture caused by the ultrafine AgNPs on UiO-66, leading to protein leakage and generation of intracellular reactive oxygen species. Then, U/A was loaded onto Ti substrates (Ti-U/A) by using self-assembly deposition methods to construct an antibacterial surface coating. Ti-U/A exhibited excellent antibacterial activities and desired biocompatibility both in vitro and in vivo. The U/A nanocomposite coating technique is thus expected to be used as a promising surface modification strategy for Ti-based dental implants for preventing dental implant infections.

Study of the f_{0}(980) and f_{0}(500) Scalar Mesons through the Decay D_{s}^{+}→π^{+}π^{-}e^{+}ν_{e}

Using e^{+}e^{-} collision data corresponding to an integrated luminosity of 7.33  fb^{-1} recorded by the BESIII detector at center-of-mass energies between 4.128 and 4.226 GeV, we present an analysis of the decay D_{s}^{+}→π^{+}π^{-}e^{+}ν_{e}, where the D_{s}^{+} is produced via the process e^{+}e^{-}→D_{s}^{*±}D_{s}^{∓}. We observe the f_{0}(980) in the π^{+}π^{-} system and the branching fraction of the decay D_{s}^{+}→f_{0}(980)e^{+}ν_{e} with f_{0}(980)→π^{+}π^{-} measured to be (1.72±0.13_{stat}±0.10_{syst})×10^{-3}, where the uncertainties are statistical and systematic, respectively. The dynamics of the D_{s}^{+}→f_{0}(980)e^{+}ν_{e} decay are studied with the simple pole parametrization of the hadronic form factor and the Flatté formula describing the f_{0}(980) in the differential decay rate, and the product of the form factor f_{+}^{f_{0}}(0) and the c→s Cabibbo-Kobayashi-Maskawa matrix element |V_{cs}| is determined for the first time to be f_{+}^{f_{0}}(0)|V_{cs}|=0.504±0.017_{stat}±0.035_{syst}. Furthermore, the decay D_{s}^{+}→f_{0}(500)e^{+}ν_{e} is searched for the first time but no signal is found. The upper limit on the branching fraction of D_{s}^{+}→f_{0}(500)e^{+}ν_{e}, f_{0}(500)→π^{+}π^{-} decay is set to be 3.3×10^{-4} at 90% confidence level.

Effect of COVID-19 infection on pregnant women in plateau regions

OBJECTIVE

The present study aims to explore the effect of COVID-19 infection on pregnant women in plateau regions.

STUDY DESIGN

Data from 381 pregnant women infected with COVID-19 who underwent prenatal examination or treatment at Women and Children's Hospital of Tibet Autonomous Region between January 2020 and December 2022 and 314 pregnant women not infected with COVID-19 were retrospectively collected.

METHODS

The study participants were divided into an infected and non-infected group according to whether they were infected with COVID-19. Basic information (ethnicity, age, body mass index and gestational age [GA]), vaccination status, intensive care unit (ICU) admission and delivery outcomes were compared. Binary logistic regression was used to analyse the influencing factors of ICU admission.

RESULTS

The results revealed significant differences in the GA, vaccination rate, blood pressure, partial pressure of oxygen, white blood cell (WBC) count, ICU admission rate, preeclampsia rate, forearm presentation rate, thrombocytopenia rate, syphilis infection rate and placental abruption rate between the two groups (P < 0.05). A univariate analysis showed that COVID-19 infection, hepatitis B virus infection, the WBC count and hypoproteinaemia were risk factors for ICU admission. The results of the multivariate analysis of the ICU admission of pregnant women showed that COVID-19 infection (odds ratio [OR] = 4.271, 95 % confidence interval [CI]: 3.572-5.820, P < 0.05) was a risk factor for ICU admission and the WBC count (OR = 0.935, 95 % CI: 0.874-0.947, P < 0.05) was a protective factor for ICU admission.

CONCLUSION

Pregnant women are vulnerable to the adverse consequences of COVID-19 infection, and public health measures such as vaccination are needed to protect this population subgroup.

[Dynamic observation on capillarization of liver sinusoidal endothelial cells induced by Echinococcus multilocularis infection]

OBJECTIVE

To investigate the capillarization of liver sinusoidal endothelial cells (LSECs) and its association with hepatic fibrosis during the development of alveolar echinococcosis, so as to provide the basis for unraveling the mechanisms underlying the role of LSEC in the development and prognosis of hepatic injuries and hepatic fibrosis caused by alveolar echinococcosis.

METHODS

Forty C57BL/6 mice at ages of 6 to 8 weeks were randomly divided into a control group and 1-, 2- and 4-week infection groups, of 10 mice in each group. Each mouse in the infection groups was intraperitoneally injected with 2 000 Echinococcus multilocularis protoscoleces, while each mouse in the control group was given an equal volume of phosphate-buffered saline using the same method. All mice were sacrificed 1, 2 and 4 weeks post-infection and mouse livers were collected. The pathological changes of livers were observed using hematoxylin-eosin (HE) staining, and hepatic fibrosis was evaluated through semi-quantitative analysis of Masson's trichrome staining-positive areas. The activation of hepatic stellate cells (HSCs) and extracellular matrix (ECM) deposition were examined using immunohistochemical staining of α-smooth muscle actin (α-SMA) and collagen type I alpha 1 (COL1A1), and the fenestrations on the surface of LSECs were observed using scanning electron microscopy. Primary LSECs were isolated from mouse livers, and the mRNA expression of LSEC marker genes Stabilin-1, Stabilin-2, Ehd3, CD209b, GATA4 and Maf was quantified using real-time fluorescence quantitative PCR (qPCR) assay.

RESULTS

Destruction of local liver lobular structure was observed in mice 2 weeks post-infection with E. multilocularis protoscoleces, and hydatid cysts, which were surrounded by granulomatous tissues, were found in mouse livers 4 weeks post-infection. Semi-quantitative analysis of Masson's trichrome staining showed a significant difference in the proportion of collagen fiber contents in mouse livers among the four groups (F = 26.060, P < 0.001), and a higher proportion of collagen fiber contents was detected in mouse livers in the 4-week infection group [(11.29 ± 2.58)%] than in the control group (P < 0.001). Immunohistochemical staining revealed activation of a few HSCs and ECM deposition in mouse livers 1 and 2 weeks post-infection, and abundant brown-yellow stained α-SMA and COL1A1 were deposited in the lesion areas in mouse livers 4 weeks post-infection, which spread to surrounding tissues. Semi-quantitative analysis revealed significant differences in α-SMA (F = 7.667, P < 0.05) and COL1A1 expression (F = 6.530, P < 0.05) in mouse levers among the four groups, with higher α-SMA [(7.13 ± 3.68)%] and COL1A1 expression [(13.18 ± 7.20)%] quantified in mouse livers in the 4-week infection group than in the control group (both P values < 0.05). Scanning electron microscopy revealed significant differences in the fenestration frequency (F = 37.730, P < 0.001) and porosity (F = 16.010, P < 0.001) on the surface of mouse LSECs among the four groups, and reduced fenestration frequency and porosity were observed in the 1-[(1.22 ± 0.48)/μm2 and [(3.05 ± 0.91)%] and 2-week infection groups [(3.47 ± 0.10)/μm2 and (7.57 ± 0.23)%] groups than in the control group (all P values < 0.001). There was a significant difference in the average fenestration diameter on the surface of mouse LSECs among the four groups (F = 15.330, P < 0.001), and larger average fenestration diameters were measured in the 1-[(180.80 ± 16.42) nm] and 2-week infection groups [(161.70 ± 3.85) nm] than in the control group (both P values < 0.05). In addition, there were significant differences among the four groups in terms of Stabilin-1 (F = 153.100, P < 0.001), Stabilin-2 (F = 57.010, P < 0.001), Ehd3 (F = 31.700, P < 0.001), CD209b (F = 177.400, P < 0.001), GATA4 (F = 17.740, P < 0.001), and Maf mRNA expression (F = 72.710, P < 0.001), and reduced mRNA expression of Stabilin-1, Stabilin-2, Ehd3, CD209b, GATA4 and Maf genes was quantified in three infection groups than in the control group (all P values < 0.001).

CONCLUSIONS

E. multilocularis infections may induce capillarization of LSECs in mice, and result in a reduction in the expression of functional and phenotypic marker genes of LSECs, and capillarization of LSECs occurs earlier than activation of HSC and development of hepatic fibrosis.

Observation of D^{+}→K_{S}^{0}a_{0}(980)^{+} in the Amplitude Analysis of D^{+}→K_{S}^{0}π^{+}η

We perform for the first time an amplitude analysis of the decay D^{+}→K_{S}^{0}π^{+}η and report the observation of the decay D^{+}→K_{S}^{0}a_{0}(980)^{+} using 2.93  fb^{-1} of e^{+}e^{-} collision data taken at a center-of-mass energy of 3.773 GeV with the BESIII detector. As the only W-annihilation-free decay among D to a_{0}(980) pseudoscalar, D^{+}→K_{S}^{0}a_{0}(980)^{+} is the ideal decay in extracting the contributions of the W-emission amplitudes involving a_{0}(980) and to study the final-state interactions. The absolute branching fraction of D^{+}→K_{S}^{0}π^{+}η is measured to be (1.27±0.04_{stat}±0.03_{syst})%. The branching fractions of intermediate processes D^{+}→K_{S}^{0}a_{0}(980)^{+} with a_{0}(980)^{+}→π^{+}η and D^{+}→π^{+}K[over ¯]_{0}^{*}(1430)^{0} with K[over ¯]_{0}^{*}(1430)^{0}→K_{S}^{0}η are measured to be (1.33±0.05_{stat}±0.04_{syst})% and (0.14±0.03_{stat}±0.01_{syst})%, respectively.

Observation of Significant Flavor-SU(3) Breaking in the Kaon Wave Function at 12<Q^{2}<25 GeV^{2} and Discovery of the Charmless Decay ψ(3770)→K_{S}^{0}K_{L}^{0}

We present cross sections for the reaction e^{+}e^{-}→K_{S}^{0}K_{L}^{0} at center-of-mass energies ranging from 3.51 to 4.95 GeV using data samples collected in the BESIII experiment, corresponding to a total integrated luminosity of 26.5  fb^{-1}. The ratio of neutral-to-charged kaon form factors at large momentum transfers (12 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

M Ablikim Institute of High Energy Physics, Beijing 100049, People's Republic of China
M N Achasov Budker Institute of Nuclear Physics SB RAS (BINP), Novosibirsk 630090, Russia
P Adlarson Uppsala University, Box 516, SE-75120 Uppsala, Sweden
X C Ai Zhengzhou University, Zhengzhou 450001, People's Republic of China
R Aliberti Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
A Amoroso University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
M R An Liaoning Normal University, Dalian 116029, People's Republic of China
Q An State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Y Bai Southeast University, Nanjing 211100, People's Republic of China
O Bakina Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
I Balossino INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy
Y Ban Peking University, Beijing 100871, People's Republic of China
H-R Bao University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
V Batozskaya Institute of High Energy Physics, Beijing 100049, People's Republic of China National Centre for Nuclear Research, Warsaw 02-093, Poland
K Begzsuren Institute of Physics and Technology, Peace Avenue 54B, Ulaanbaatar 13330, Mongolia
N Berger Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
M Berlowski National Centre for Nuclear Research, Warsaw 02-093, Poland
M Bertani INFN Laboratori Nazionali di Frascati, INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
D Bettoni INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy
F Bianchi University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
E Bianco University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
A Bortone University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
I Boyko Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
R A Briere Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, USA
A Brueggemann University of Muenster, Wilhelm-Klemm-Strasse 9, 48149 Muenster, Germany
H Cai Wuhan University, Wuhan 430072, People's Republic of China
X Cai Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
A Calcaterra INFN Laboratori Nazionali di Frascati, INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
G F Cao Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
N Cao Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S A Cetin Turkish Accelerator Center Particle Factory Group, Istinye University, 34010 Istanbul, Turkey
J F Chang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
T T Chang Xinyang Normal University, Xinyang 464000, People's Republic of China
W L Chang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
G R Che Nankai University, Tianjin 300071, People's Republic of China
G Chelkov Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
C Chen Nankai University, Tianjin 300071, People's Republic of China
Chao Chen Soochow University, Suzhou 215006, People's Republic of China
G Chen Institute of High Energy Physics, Beijing 100049, People's Republic of China
H S Chen Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
M L Chen Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S J Chen Nanjing University, Nanjing 210093, People's Republic of China
S L Chen North China Electric Power University, Beijing 102206, People's Republic of China
S M Chen Tsinghua University, Beijing 100084, People's Republic of China
T Chen Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X R Chen Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X T Chen Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y B Chen Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Y Q Chen Jilin University, Changchun 130012, People's Republic of China
Z J Chen Hunan University, Changsha 410082, People's Republic of China
S K Choi Chung-Ang University, Seoul, 06974, Republic of Korea
X Chu Nankai University, Tianjin 300071, People's Republic of China
G Cibinetto INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy
S C Coen Bochum Ruhr-University, D-44780 Bochum, Germany
F Cossio INFN, I-10125, Turin, Italy
J J Cui Shandong University, Jinan 250100, People's Republic of China
H L Dai Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
J P Dai Yunnan University, Kunming 650500, People's Republic of China
A Dbeyssi Helmholtz Institute Mainz, Staudinger Weg 18, D-55099 Mainz, Germany
R E de Boer Bochum Ruhr-University, D-44780 Bochum, Germany
D Dedovich Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
Z Y Deng Institute of High Energy Physics, Beijing 100049, People's Republic of China
A Denig Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
I Denysenko Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
M Destefanis University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
F De Mori University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
B Ding Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Jinan, Jinan 250022, People's Republic of China
X X Ding Peking University, Beijing 100871, People's Republic of China
Y Ding Liaoning University, Shenyang 110036, People's Republic of China
Y Ding Jilin University, Changchun 130012, People's Republic of China
J Dong Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
L Y Dong Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
M Y Dong Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Dong Wuhan University, Wuhan 430072, People's Republic of China
M C Du Institute of High Energy Physics, Beijing 100049, People's Republic of China
S X Du Zhengzhou University, Zhengzhou 450001, People's Republic of China
Z H Duan Nanjing University, Nanjing 210093, People's Republic of China
P Egorov Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
Y H Fan North China Electric Power University, Beijing 102206, People's Republic of China
J Fang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
S S Fang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
W X Fang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Y Fang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Y Q Fang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
R Farinelli INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy
L Fava University of Eastern Piedmont, I-15121 Alessandria, Italy INFN, I-10125, Turin, Italy
F Feldbauer Bochum Ruhr-University, D-44780 Bochum, Germany
G Felici INFN Laboratori Nazionali di Frascati, INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
C Q Feng State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
J H Feng Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
K Fischer University of Oxford, Keble Road, Oxford OX13RH, United Kingdom
M Fritsch Bochum Ruhr-University, D-44780 Bochum, Germany
C D Fu Institute of High Energy Physics, Beijing 100049, People's Republic of China
J L Fu University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y W Fu Institute of High Energy Physics, Beijing 100049, People's Republic of China
H Gao University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y N Gao Peking University, Beijing 100871, People's Republic of China
Yang Gao State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
S Garbolino INFN, I-10125, Turin, Italy
I Garzia INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy University of Ferrara, I-44122 Ferrara, Italy
P T Ge Wuhan University, Wuhan 430072, People's Republic of China
Z W Ge Nanjing University, Nanjing 210093, People's Republic of China
C Geng Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
E M Gersabeck University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
A Gilman University of Oxford, Keble Road, Oxford OX13RH, United Kingdom
K Goetzen GSI Helmholtzcentre for Heavy Ion Research GmbH, D-64291 Darmstadt, Germany
L Gong Liaoning University, Shenyang 110036, People's Republic of China
W X Gong Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
W Gradl Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
S Gramigna INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy University of Ferrara, I-44122 Ferrara, Italy
M Greco University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
M H Gu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Y T Gu Guangxi University, Nanning 530004, People's Republic of China
C Y Guan Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z L Guan Henan University of Technology, Zhengzhou 450001, People's Republic of China
A Q Guo Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
L B Guo Nanjing Normal University, Nanjing 210023, People's Republic of China
M J Guo Shandong University, Jinan 250100, People's Republic of China
R P Guo Shandong Normal University, Jinan 250014, People's Republic of China
Y P Guo Fudan University, Shanghai 200433, People's Republic of China
A Guskov Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
J Gutierrez Indiana University, Bloomington, Indiana 47405, USA
T T Han Institute of High Energy Physics, Beijing 100049, People's Republic of China
W Y Han Liaoning Normal University, Dalian 116029, People's Republic of China
X Q Hao Henan Normal University, Xinxiang 453007, People's Republic of China
F A Harris University of Hawaii, Honolulu, Hawaii 96822, USA
K K He Soochow University, Suzhou 215006, People's Republic of China
K L He Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
F H H Heinsius Bochum Ruhr-University, D-44780 Bochum, Germany
C H Heinz Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
Y K Heng Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
C Herold Suranaree University of Technology, University Avenue 111, Nakhon Ratchasima 30000, Thailand
T Holtmann Bochum Ruhr-University, D-44780 Bochum, Germany
P C Hong Fudan University, Shanghai 200433, People's Republic of China
G Y Hou Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X T Hou Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y R Hou University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z L Hou Institute of High Energy Physics, Beijing 100049, People's Republic of China
B Y Hu Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
H M Hu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J F Hu South China Normal University, Guangzhou 510006, People's Republic of China
T Hu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y Hu Institute of High Energy Physics, Beijing 100049, People's Republic of China
G S Huang State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
K X Huang Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
L Q Huang Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X T Huang Shandong University, Jinan 250100, People's Republic of China
Y P Huang Institute of High Energy Physics, Beijing 100049, People's Republic of China
T Hussain University of the Punjab, Lahore-54590, Pakistan
N Hüsken Indiana University, Bloomington, Indiana 47405, USA Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
N In der Wiesche University of Muenster, Wilhelm-Klemm-Strasse 9, 48149 Muenster, Germany
M Irshad State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
J Jackson Indiana University, Bloomington, Indiana 47405, USA
S Jaeger Bochum Ruhr-University, D-44780 Bochum, Germany
S Janchiv Institute of Physics and Technology, Peace Avenue 54B, Ulaanbaatar 13330, Mongolia
J H Jeong Chung-Ang University, Seoul, 06974, Republic of Korea
Q Ji Institute of High Energy Physics, Beijing 100049, People's Republic of China
Q P Ji Henan Normal University, Xinxiang 453007, People's Republic of China
X B Ji Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X L Ji Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Y Y Ji Shandong University, Jinan 250100, People's Republic of China
X Q Jia Shandong University, Jinan 250100, People's Republic of China
Z K Jia State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
H J Jiang Wuhan University, Wuhan 430072, People's Republic of China
P C Jiang Peking University, Beijing 100871, People's Republic of China
S S Jiang Liaoning Normal University, Dalian 116029, People's Republic of China
T J Jiang Hangzhou Normal University, Hangzhou 310036, People's Republic of China
X S Jiang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y Jiang University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J B Jiao Shandong University, Jinan 250100, People's Republic of China
Z Jiao Huangshan College, Huangshan 245000, People's Republic of China
S Jin Nanjing University, Nanjing 210093, People's Republic of China
Y Jin University of Jinan, Jinan 250022, People's Republic of China
M Q Jing Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X M Jing University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
T Johansson Uppsala University, Box 516, SE-75120 Uppsala, Sweden
X Kui Institute of High Energy Physics, Beijing 100049, People's Republic of China
S Kabana Instituto de Alta Investigación, Universidad de Tarapacá, Casilla 7D, Arica 1000000, Chile
N Kalantar-Nayestanaki University of Groningen, NL-9747 AA Groningen, The Netherlands
X L Kang China University of Geosciences, Wuhan 430074, People's Republic of China
X S Kang Liaoning University, Shenyang 110036, People's Republic of China
M Kavatsyuk University of Groningen, NL-9747 AA Groningen, The Netherlands
B C Ke Zhengzhou University, Zhengzhou 450001, People's Republic of China
V Khachatryan Indiana University, Bloomington, Indiana 47405, USA
A Khoukaz University of Muenster, Wilhelm-Klemm-Strasse 9, 48149 Muenster, Germany
R Kiuchi Institute of High Energy Physics, Beijing 100049, People's Republic of China
R Kliemt GSI Helmholtzcentre for Heavy Ion Research GmbH, D-64291 Darmstadt, Germany
O B Kolcu Turkish Accelerator Center Particle Factory Group, Istinye University, 34010 Istanbul, Turkey
B Kopf Bochum Ruhr-University, D-44780 Bochum, Germany
M Kuessner Bochum Ruhr-University, D-44780 Bochum, Germany
A Kupsc National Centre for Nuclear Research, Warsaw 02-093, Poland Uppsala University, Box 516, SE-75120 Uppsala, Sweden
W Kühn Justus-Liebig-Universitaet Giessen, II. Physikalisches Institut, Heinrich-Buff-Ring 16, D-35392 Giessen, Germany
J J Lane University of Manchester, Oxford Road, Manchester, M13 9PL, United Kingdom
P Larin Helmholtz Institute Mainz, Staudinger Weg 18, D-55099 Mainz, Germany
A Lavania Indian Institute of Technology Madras, Chennai 600036, India
L Lavezzi University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
T T Lei State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Z H Lei State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
H Leithoff Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
M Lellmann Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
T Lenz Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
C Li Qufu Normal University, Qufu 273165, People's Republic of China
C Li Nankai University, Tianjin 300071, People's Republic of China
C H Li Liaoning Normal University, Dalian 116029, People's Republic of China
Cheng Li State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
D M Li Zhengzhou University, Zhengzhou 450001, People's Republic of China
F Li Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
G Li Institute of High Energy Physics, Beijing 100049, People's Republic of China
H Li State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
H B Li Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
H J Li Henan Normal University, Xinxiang 453007, People's Republic of China
H N Li South China Normal University, Guangzhou 510006, People's Republic of China
Hui Li Nankai University, Tianjin 300071, People's Republic of China
J R Li Tsinghua University, Beijing 100084, People's Republic of China
J S Li Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
J W Li Shandong University, Jinan 250100, People's Republic of China
Ke Li Institute of High Energy Physics, Beijing 100049, People's Republic of China
L J Li Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
L K Li Institute of High Energy Physics, Beijing 100049, People's Republic of China
Lei Li Renmin University of China, Beijing 100872, People's Republic of China
M H Li Nankai University, Tianjin 300071, People's Republic of China
P R Li Lanzhou University, Lanzhou 730000, People's Republic of China
Q X Li Shandong University, Jinan 250100, People's Republic of China
S X Li Fudan University, Shanghai 200433, People's Republic of China
T Li Shandong University, Jinan 250100, People's Republic of China
W D Li Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
W G Li Institute of High Energy Physics, Beijing 100049, People's Republic of China
X H Li State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
X L Li Shandong University, Jinan 250100, People's Republic of China
Xiaoyu Li Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y G Li Peking University, Beijing 100871, People's Republic of China
Z J Li Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
Z X Li Guangxi University, Nanning 530004, People's Republic of China
C Liang Nanjing University, Nanjing 210093, People's Republic of China
H Liang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
H Liang State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Y F Liang Sichuan University, Chengdu 610064, People's Republic of China
Y T Liang Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
G R Liao Guangxi Normal University, Guilin 541004, People's Republic of China
L Z Liao Shandong University, Jinan 250100, People's Republic of China
Y P Liao Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J Libby Indian Institute of Technology Madras, Chennai 600036, India
A Limphirat Suranaree University of Technology, University Avenue 111, Nakhon Ratchasima 30000, Thailand
D X Lin Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
T Lin Institute of High Energy Physics, Beijing 100049, People's Republic of China
B J Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China
B X Liu Wuhan University, Wuhan 430072, People's Republic of China
C Liu Jilin University, Changchun 130012, People's Republic of China
C X Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China
F H Liu Shanxi University, Taiyuan 030006, People's Republic of China
Fang Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China
Feng Liu Central China Normal University, Wuhan 430079, People's Republic of China
G M Liu South China Normal University, Guangzhou 510006, People's Republic of China
H Liu Lanzhou University, Lanzhou 730000, People's Republic of China
H B Liu Guangxi University, Nanning 530004, People's Republic of China
H M Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Huanhuan Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China
Huihui Liu Henan University of Science and Technology, Luoyang 471003, People's Republic of China
J B Liu State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
J Y Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
K Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China
K Y Liu Liaoning University, Shenyang 110036, People's Republic of China
Ke Liu Henan University of Technology, Zhengzhou 450001, People's Republic of China
L Liu State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
L C Liu Nankai University, Tianjin 300071, People's Republic of China
Lu Liu Nankai University, Tianjin 300071, People's Republic of China
M H Liu Fudan University, Shanghai 200433, People's Republic of China
P L Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China
Q Liu University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S B Liu State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
T Liu Fudan University, Shanghai 200433, People's Republic of China
W K Liu Nankai University, Tianjin 300071, People's Republic of China
W M Liu State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
X Liu Lanzhou University, Lanzhou 730000, People's Republic of China
Y Liu Lanzhou University, Lanzhou 730000, People's Republic of China
Y Liu Zhengzhou University, Zhengzhou 450001, People's Republic of China
Y B Liu Nankai University, Tianjin 300071, People's Republic of China
Z A Liu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z Q Liu Shandong University, Jinan 250100, People's Republic of China
X C Lou Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
F X Lu Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
H J Lu Huangshan College, Huangshan 245000, People's Republic of China
J G Lu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
X L Lu Institute of High Energy Physics, Beijing 100049, People's Republic of China
Y Lu Central South University, Changsha 410083, People's Republic of China
Y P Lu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Z H Lu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
C L Luo Nanjing Normal University, Nanjing 210023, People's Republic of China
M X Luo Zhejiang University, Hangzhou 310027, People's Republic of China
T Luo Fudan University, Shanghai 200433, People's Republic of China
X L Luo Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
X R Lyu University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y F Lyu Nankai University, Tianjin 300071, People's Republic of China
F C Ma Liaoning University, Shenyang 110036, People's Republic of China
H Ma Yunnan University, Kunming 650500, People's Republic of China
H L Ma Institute of High Energy Physics, Beijing 100049, People's Republic of China
J L Ma Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
L L Ma Shandong University, Jinan 250100, People's Republic of China
M M Ma Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Q M Ma Institute of High Energy Physics, Beijing 100049, People's Republic of China
R Q Ma Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Y Ma Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Y Ma Peking University, Beijing 100871, People's Republic of China
Y M Ma Institute of Modern Physics, Lanzhou 730000, People's Republic of China
F E Maas Helmholtz Institute Mainz, Staudinger Weg 18, D-55099 Mainz, Germany
M Maggiora University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
S Malde University of Oxford, Keble Road, Oxford OX13RH, United Kingdom
Q A Malik University of the Punjab, Lahore-54590, Pakistan
A Mangoni INFN Sezione di Perugia, I-06100 Perugia, Italy
Y J Mao Peking University, Beijing 100871, People's Republic of China
Z P Mao Institute of High Energy Physics, Beijing 100049, People's Republic of China
S Marcello University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
Z X Meng University of Jinan, Jinan 250022, People's Republic of China
J G Messchendorp GSI Helmholtzcentre for Heavy Ion Research GmbH, D-64291 Darmstadt, Germany University of Groningen, NL-9747 AA Groningen, The Netherlands
G Mezzadri INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy
H Miao Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
T J Min Nanjing University, Nanjing 210093, People's Republic of China
R E Mitchell Indiana University, Bloomington, Indiana 47405, USA
X H Mo Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
B Moses Indiana University, Bloomington, Indiana 47405, USA
N Yu Muchnoi Budker Institute of Nuclear Physics SB RAS (BINP), Novosibirsk 630090, Russia
J Muskalla Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
Y Nefedov Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
F Nerling Helmholtz Institute Mainz, Staudinger Weg 18, D-55099 Mainz, Germany
I B Nikolaev Budker Institute of Nuclear Physics SB RAS (BINP), Novosibirsk 630090, Russia
Z Ning Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
S Nisar COMSATS University Islamabad, Lahore Campus, Defence Road, Off Raiwind Road, 54000 Lahore, Pakistan
Q L Niu Lanzhou University, Lanzhou 730000, People's Republic of China
W D Niu Soochow University, Suzhou 215006, People's Republic of China
Y Niu Shandong University, Jinan 250100, People's Republic of China
S L Olsen University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Q Ouyang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S Pacetti INFN Sezione di Perugia, I-06100 Perugia, Italy University of Perugia, I-06100 Perugia, Italy
X Pan Soochow University, Suzhou 215006, People's Republic of China
Y Pan Southeast University, Nanjing 211100, People's Republic of China
A Pathak Jilin University, Changchun 130012, People's Republic of China
P Patteri INFN Laboratori Nazionali di Frascati, INFN Laboratori Nazionali di Frascati, I-00044 Frascati, Italy
Y P Pei State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
M Pelizaeus Bochum Ruhr-University, D-44780 Bochum, Germany
H P Peng State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Y Y Peng Lanzhou University, Lanzhou 730000, People's Republic of China
K Peters GSI Helmholtzcentre for Heavy Ion Research GmbH, D-64291 Darmstadt, Germany
J L Ping Nanjing Normal University, Nanjing 210023, People's Republic of China
R G Ping Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S Plura Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
V Prasad Instituto de Alta Investigación, Universidad de Tarapacá, Casilla 7D, Arica 1000000, Chile
F Z Qi Institute of High Energy Physics, Beijing 100049, People's Republic of China
H Qi State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
H R Qi Tsinghua University, Beijing 100084, People's Republic of China
M Qi Nanjing University, Nanjing 210093, People's Republic of China
T Y Qi Fudan University, Shanghai 200433, People's Republic of China
S Qian Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
W B Qian University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
C F Qiao University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J J Qin University of South China, Hengyang 421001, People's Republic of China
L Q Qin Guangxi Normal University, Guilin 541004, People's Republic of China
X S Qin Shandong University, Jinan 250100, People's Republic of China
Z H Qin Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
J F Qiu Institute of High Energy Physics, Beijing 100049, People's Republic of China
S Q Qu Tsinghua University, Beijing 100084, People's Republic of China
C F Redmer Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
K J Ren Liaoning Normal University, Dalian 116029, People's Republic of China
A Rivetti INFN, I-10125, Turin, Italy
M Rolo INFN, I-10125, Turin, Italy
G Rong Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Ch Rosner Helmholtz Institute Mainz, Staudinger Weg 18, D-55099 Mainz, Germany
S N Ruan Nankai University, Tianjin 300071, People's Republic of China
N Salone National Centre for Nuclear Research, Warsaw 02-093, Poland
A Sarantsev Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
Y Schelhaas Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
K Schoenning Uppsala University, Box 516, SE-75120 Uppsala, Sweden
M Scodeggio INFN Sezione di Ferrara, INFN Sezione di Ferrara, I-44122 Ferrara, Italy University of Ferrara, I-44122 Ferrara, Italy
K Y Shan Fudan University, Shanghai 200433, People's Republic of China
W Shan Hunan Normal University, Changsha 410081, People's Republic of China
X Y Shan State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
J F Shangguan Soochow University, Suzhou 215006, People's Republic of China
L G Shao Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
M Shao State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
C P Shen Fudan University, Shanghai 200433, People's Republic of China
H F Shen Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
W H Shen University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Y Shen Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
B A Shi University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
H C Shi State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
J L Shi Fudan University, Shanghai 200433, People's Republic of China
J Y Shi Institute of High Energy Physics, Beijing 100049, People's Republic of China
Q Q Shi Soochow University, Suzhou 215006, People's Republic of China
R S Shi Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Shi Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
J J Song Henan Normal University, Xinxiang 453007, People's Republic of China
T Z Song Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
W M Song Institute of High Energy Physics, Beijing 100049, People's Republic of China Jilin University, Changchun 130012, People's Republic of China
Y J Song Fudan University, Shanghai 200433, People's Republic of China
Y X Song Peking University, Beijing 100871, People's Republic of China
S Sosio University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
S Spataro University of Turin and INFN, University of Turin, I-10125 Turin, Italy INFN, I-10125, Turin, Italy
F Stieler Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 45, D-55099 Mainz, Germany
Y J Su University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
G B Sun Wuhan University, Wuhan 430072, People's Republic of China
G X Sun Institute of High Energy Physics, Beijing 100049, People's Republic of China
H Sun University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
H K Sun Institute of High Energy Physics, Beijing 100049, People's Republic of China
J F Sun Henan Normal University, Xinxiang 453007, People's Republic of China
K Sun Tsinghua University, Beijing 100084, People's Republic of China
L Sun Wuhan University, Wuhan 430072, People's Republic of China
S S Sun Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
T Sun Shanghai Jiao Tong University, Shanghai 200240, People's Republic of China
W Y Sun Jilin University, Changchun 130012, People's Republic of China
Y Sun China University of Geosciences, Wuhan 430074, People's Republic of China
Y J Sun State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Y Z Sun Institute of High Energy Physics, Beijing 100049, People's Republic of China
Z T Sun Shandong University, Jinan 250100, People's Republic of China
Y X Tan State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
C J Tang Sichuan University, Chengdu 610064, People's Republic of China
G Y Tang Institute of High Energy Physics, Beijing 100049, People's Republic of China
J Tang Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
Y A Tang Wuhan University, Wuhan 430072, People's Republic of China
L Y Tao University of South China, Hengyang 421001, People's Republic of China
Q T Tao Hunan University, Changsha 410082, People's Republic of China
M Tat University of Oxford, Keble Road, Oxford OX13RH, United Kingdom
J X Teng State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
V Thoren Uppsala University, Box 516, SE-75120 Uppsala, Sweden
W H Tian Shanxi Normal University, Linfen 041004, People's Republic of China
W H Tian Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
Y Tian Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z F Tian Wuhan University, Wuhan 430072, People's Republic of China
I Uman Near East University, Nicosia, North Cyprus, 99138, Mersin 10, Turkey
Y Wan Soochow University, Suzhou 215006, People's Republic of China
S J Wang Shandong University, Jinan 250100, People's Republic of China
B Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China
B L Wang University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Bo Wang State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
C W Wang Nanjing University, Nanjing 210093, People's Republic of China
D Y Wang Peking University, Beijing 100871, People's Republic of China
F Wang University of South China, Hengyang 421001, People's Republic of China
H J Wang Lanzhou University, Lanzhou 730000, People's Republic of China
J P Wang Shandong University, Jinan 250100, People's Republic of China
K Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
L L Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China
M Wang Shandong University, Jinan 250100, People's Republic of China
Meng Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
N Y Wang University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S Wang Fudan University, Shanghai 200433, People's Republic of China
S Wang Lanzhou University, Lanzhou 730000, People's Republic of China
T Wang Fudan University, Shanghai 200433, People's Republic of China
T J Wang Nankai University, Tianjin 300071, People's Republic of China
W Wang Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
W Wang University of South China, Hengyang 421001, People's Republic of China
W P Wang State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
X Wang Peking University, Beijing 100871, People's Republic of China
X F Wang Lanzhou University, Lanzhou 730000, People's Republic of China
X J Wang Liaoning Normal University, Dalian 116029, People's Republic of China
X L Wang Fudan University, Shanghai 200433, People's Republic of China
Y Wang Tsinghua University, Beijing 100084, People's Republic of China
Y D Wang North China Electric Power University, Beijing 102206, People's Republic of China
Y F Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y L Wang Henan Normal University, Xinxiang 453007, People's Republic of China
Y N Wang North China Electric Power University, Beijing 102206, People's Republic of China
Y Q Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Yaqian Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China Hebei University, Baoding 071002, People's Republic of China
Yi Wang Tsinghua University, Beijing 100084, People's Republic of China
Z Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Z L Wang University of South China, Hengyang 421001, People's Republic of China
Z Y Wang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Ziyi Wang University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
D Wei University of Science and Technology Liaoning, Anshan 114051, People's Republic of China
D H Wei Guangxi Normal University, Guilin 541004, People's Republic of China
F Weidner University of Muenster, Wilhelm-Klemm-Strasse 9, 48149 Muenster, Germany
S P Wen Institute of High Energy Physics, Beijing 100049, People's Republic of China
C W Wenzel Bochum Ruhr-University, D-44780 Bochum, Germany
U Wiedner Bochum Ruhr-University, D-44780 Bochum, Germany
G Wilkinson University of Oxford, Keble Road, Oxford OX13RH, United Kingdom
M Wolke Uppsala University, Box 516, SE-75120 Uppsala, Sweden
L Wollenberg Bochum Ruhr-University, D-44780 Bochum, Germany
C Wu Liaoning Normal University, Dalian 116029, People's Republic of China
J F Wu Institute of High Energy Physics, Beijing 100049, People's Republic of China China Center of Advanced Science and Technology, Beijing 100190, People's Republic of China
L H Wu Institute of High Energy Physics, Beijing 100049, People's Republic of China
L J Wu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Wu Fudan University, Shanghai 200433, People's Republic of China
X H Wu Jilin University, Changchun 130012, People's Republic of China
Y Wu University of Science and Technology of China, Hefei 230026, People's Republic of China
Y H Wu Soochow University, Suzhou 215006, People's Republic of China
Y J Wu Institute of Modern Physics, Lanzhou 730000, People's Republic of China
Z Wu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
L Xia State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
X M Xian Liaoning Normal University, Dalian 116029, People's Republic of China
T Xiang Peking University, Beijing 100871, People's Republic of China
D Xiao Lanzhou University, Lanzhou 730000, People's Republic of China
G Y Xiao Nanjing University, Nanjing 210093, People's Republic of China
S Y Xiao Institute of High Energy Physics, Beijing 100049, People's Republic of China
Y L Xiao Fudan University, Shanghai 200433, People's Republic of China
Z J Xiao Nanjing Normal University, Nanjing 210023, People's Republic of China
C Xie Nanjing University, Nanjing 210093, People's Republic of China
X H Xie Peking University, Beijing 100871, People's Republic of China
Y Xie Shandong University, Jinan 250100, People's Republic of China
Y G Xie Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Y H Xie Central China Normal University, Wuhan 430079, People's Republic of China
Z P Xie State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
T Y Xing Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
C F Xu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
C J Xu Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
G F Xu Institute of High Energy Physics, Beijing 100049, People's Republic of China
H Y Xu University of Jinan, Jinan 250022, People's Republic of China
Q J Xu Hangzhou Normal University, Hangzhou 310036, People's Republic of China
Q N Xu Inner Mongolia University, Hohhot 010021, People's Republic of China
W Xu Institute of High Energy Physics, Beijing 100049, People's Republic of China
W L Xu University of Jinan, Jinan 250022, People's Republic of China
X P Xu Soochow University, Suzhou 215006, People's Republic of China
Y C Xu Yantai University, Yantai 264005, People's Republic of China
Z P Xu Nanjing University, Nanjing 210093, People's Republic of China
Z S Xu University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
F Yan Fudan University, Shanghai 200433, People's Republic of China
L Yan Fudan University, Shanghai 200433, People's Republic of China
W B Yan State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
W C Yan Zhengzhou University, Zhengzhou 450001, People's Republic of China
X Q Yan Institute of High Energy Physics, Beijing 100049, People's Republic of China
H J Yang Shanghai Jiao Tong University, Shanghai 200240, People's Republic of China
H L Yang Jilin University, Changchun 130012, People's Republic of China
H X Yang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Tao Yang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Y Yang Fudan University, Shanghai 200433, People's Republic of China
Y F Yang Nankai University, Tianjin 300071, People's Republic of China
Y X Yang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Yifan Yang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z W Yang Lanzhou University, Lanzhou 730000, People's Republic of China
Z P Yao Shandong University, Jinan 250100, People's Republic of China
M Ye Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
M H Ye China Center of Advanced Science and Technology, Beijing 100190, People's Republic of China
J H Yin Institute of High Energy Physics, Beijing 100049, People's Republic of China
Z Y You Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
B X Yu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
C X Yu Nankai University, Tianjin 300071, People's Republic of China
G Yu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J S Yu Hunan University, Changsha 410082, People's Republic of China
T Yu University of South China, Hengyang 421001, People's Republic of China
X D Yu Peking University, Beijing 100871, People's Republic of China
C Z Yuan Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
L Yuan Beihang University, Beijing 100191, People's Republic of China
S C Yuan Institute of High Energy Physics, Beijing 100049, People's Republic of China
Y Yuan Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z Y Yuan Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
C X Yue Liaoning Normal University, Dalian 116029, People's Republic of China
A A Zafar University of the Punjab, Lahore-54590, Pakistan
F R Zeng Shandong University, Jinan 250100, People's Republic of China
S H Zeng University of South China, Hengyang 421001, People's Republic of China
X Zeng Fudan University, Shanghai 200433, People's Republic of China
Y Zeng Hunan University, Changsha 410082, People's Republic of China
Y J Zeng Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Y Zhai Jilin University, Changchun 130012, People's Republic of China
Y C Zhai Shandong University, Jinan 250100, People's Republic of China
Y H Zhan Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
A Q Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
B L Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
B X Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China
D H Zhang Nankai University, Tianjin 300071, People's Republic of China
G Y Zhang Henan Normal University, Xinxiang 453007, People's Republic of China
H Zhang University of Science and Technology of China, Hefei 230026, People's Republic of China
H C Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
H H Zhang Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
H H Zhang Jilin University, Changchun 130012, People's Republic of China
H Q Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
H Y Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
J Zhang Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
J Zhang Zhengzhou University, Zhengzhou 450001, People's Republic of China
J J Zhang Shanxi Normal University, Linfen 041004, People's Republic of China
J L Zhang Henan University, Kaifeng 475004, People's Republic of China
J Q Zhang Nanjing Normal University, Nanjing 210023, People's Republic of China
J W Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J X Zhang Lanzhou University, Lanzhou 730000, People's Republic of China
J Y Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China
J Z Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Jianyu Zhang University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
L M Zhang Tsinghua University, Beijing 100084, People's Republic of China
L Q Zhang Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
Lei Zhang Nanjing University, Nanjing 210093, People's Republic of China
P Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Q Y Zhang Liaoning Normal University, Dalian 116029, People's Republic of China Zhengzhou University, Zhengzhou 450001, People's Republic of China
Shuihan Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Shulei Zhang Hunan University, Changsha 410082, People's Republic of China
X D Zhang North China Electric Power University, Beijing 102206, People's Republic of China
X M Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China
X Y Zhang Shandong University, Jinan 250100, People's Republic of China
Y Zhang University of South China, Hengyang 421001, People's Republic of China
Y Zhang University of Oxford, Keble Road, Oxford OX13RH, United Kingdom
Y T Zhang Zhengzhou University, Zhengzhou 450001, People's Republic of China
Y H Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Yan Zhang State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Yao Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Z D Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Z H Zhang Institute of High Energy Physics, Beijing 100049, People's Republic of China
Z L Zhang Jilin University, Changchun 130012, People's Republic of China
Z Y Zhang Nankai University, Tianjin 300071, People's Republic of China
Z Y Zhang Wuhan University, Wuhan 430072, People's Republic of China
G Zhao Institute of High Energy Physics, Beijing 100049, People's Republic of China
J Y Zhao Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J Z Zhao Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Lei Zhao State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Ling Zhao Institute of High Energy Physics, Beijing 100049, People's Republic of China
M G Zhao Nankai University, Tianjin 300071, People's Republic of China
R P Zhao University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S J Zhao Zhengzhou University, Zhengzhou 450001, People's Republic of China
Y B Zhao Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
Y X Zhao Institute of Modern Physics, Lanzhou 730000, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Z G Zhao State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
A Zhemchugov Joint Institute for Nuclear Research, 141980 Dubna, Moscow region, Russia
B Zheng University of South China, Hengyang 421001, People's Republic of China
J P Zheng Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China
W J Zheng Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
Y H Zheng University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
B Zhong Nanjing Normal University, Nanjing 210023, People's Republic of China
X Zhong Sun Yat-Sen University, Guangzhou 510275, People's Republic of China
H Zhou Shandong University, Jinan 250100, People's Republic of China
L P Zhou Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
X Zhou Wuhan University, Wuhan 430072, People's Republic of China
X K Zhou Central China Normal University, Wuhan 430079, People's Republic of China
X R Zhou State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
X Y Zhou Liaoning Normal University, Dalian 116029, People's Republic of China
Y Z Zhou Fudan University, Shanghai 200433, People's Republic of China
J Zhu Nankai University, Tianjin 300071, People's Republic of China
K Zhu Institute of High Energy Physics, Beijing 100049, People's Republic of China
K J Zhu Institute of High Energy Physics, Beijing 100049, People's Republic of China State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
L Zhu Jilin University, Changchun 130012, People's Republic of China
L X Zhu University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
S H Zhu University of Science and Technology Liaoning, Anshan 114051, People's Republic of China
S Q Zhu Nanjing University, Nanjing 210093, People's Republic of China
T J Zhu Fudan University, Shanghai 200433, People's Republic of China
W J Zhu Fudan University, Shanghai 200433, People's Republic of China
Y C Zhu State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China
Z A Zhu Institute of High Energy Physics, Beijing 100049, People's Republic of China University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China
J H Zou Institute of High Energy Physics, Beijing 100049, People's Republic of China
J Zu State Key Laboratory of Particle Detection and Electronics, Beijing 100049, Hefei 230026, People's Republic of China University of Science and Technology of China, Hefei 230026, People's Republic of China

Collapse

Flow Behavior of Entangled Polymer Nanoparticle Composites in a Nanotube: Insights into Jamming State

Using molecular dynamics simulations, this study investigates the equilibrium properties and flow behaviors of entangled polymer nanoparticle composites (PNCs) within a nanotube. The results show that the density distribution of nanoparticles (NPs), displacement of polymer chains and NPs, and the moduli of PNCs remain relatively unaffected when NP volume fractions (ΦN) ≤0.10. However, the flow behavior of entangled PNCs deviates from the ideal parabolic profile seen in unentangled PNCs, displaying plug-like flow characteristics with a significant platform region, indicating the presence of shear bands. Interestingly, entangled PNCs at intermediate ΦN values undergo a significant alteration in NP distribution under steady flow, resulting in notable NP aggregation. At ΦN = 0.30, a distinct change in the static structure of PNCs occurs, reducing the equilibrium distance between neighboring NPs. Consequently, the motion of both polymer chains and NPs becomes restricted, leading to an increase in the moduli of PNCs resembling solid-like behavior. Additionally, the entangled PNCs experience a complete absence of flow, indicating the entry into a jamming state. This study contributes to the understanding of PNCs flow behavior and provides insights into fundamental aspects and practical implications of PNCs.

[A giant malignant melanoma of the palpebral conjunctiva: a case report]

An 81-year-old female patient experienced a rapid increase in the volume of a rice-sized black mass on the left eye over a period of six months. The mass extended out of the eye and exhibited surface erosion with accompanying hemorrhage. Following a live tissue examination and histopathology after orbital exenteration under general anesthesia, the diagnosis of a giant malignant palpebral conjunctival melanoma of the spindle cell subtype was confirmed. The patient refused to undergo local radiation therapy or systemic chemotherapy and died from the disease six months later.

[A prospective study on association between sleep duration and the risk of chronic obstructive pulmonary disease in adults in Suzhou]

Objective: To investigate the prospective association of sleep duration with the development of chronic obstructive pulmonary disease (COPD) in adults in Suzhou. Methods: The study used the data of 53 269 participants aged 30-79 years recruited in the baseline survey from 2004 to 2008 and the follow-up until December 31, 2017 of China Kadoorie Biobank (CKB) conducted in Wuzhong District, Suzhou. After excluding participants with airflow limitation, self-reported chronic bronchitis/emphysema/coronary heart disease history at the baseline survey and abnormal or incomplete data, a total of 45 336 participants were included in the final analysis. The association between daily sleep duration and the risk for developing COPD was analyzed by using a Cox proportional hazard regression model, and the hazard ratio (HR) values and their 95%CI were calculated. The analysis was stratified by age, gender and lifestyle factors, and cross-analysis was conducted according to smoking status and daily sleep duration. Results: The median follow-up time was 11.12 years, with a total of 515 COPD diagnoses in the follow-up. After adjusting for potential confounders, multifactorial Cox proportional hazard regression analysis showed that daily sleep duration ≥10 hours was associated with higher risk for developing COPD (HR=1.42, 95%CI: 1.03-1.97). The cross analysis showed that excessive daily sleep duration increased the risk for COPD in smokers (HR=2.49, 95%CI: 1.35-4.59, interaction P<0.001). Conclusion: Longer daily sleep duration (≥10 hours) might increase the risk for COPD in adults in Suzhou, especially in smokers.

Investigation of the ΔI=1/2 Rule and Test of CP Symmetry through the Measurement of Decay Asymmetry Parameters in Ξ^{-} Decays

Using (10087±44)×10^{6}  J/ψ events collected with the BESIII detector, numerous Ξ^{-} and Λ decay asymmetry parameters are simultaneously determined from the process J/ψ→Ξ^{-}Ξ[over ¯]^{+}→Λ(pπ^{-})π^{-}Λ[over ¯](n[over ¯]π^{0})π^{+} and its charge-conjugate channel. The precisions of α_{Λ0} for Λ→nπ^{0} and α[over ¯]_{Λ0} for Λ[over ¯]→n[over ¯]π^{0} compared to world averages are improved by factors of 4 and 1.7, respectively. The ratio of decay asymmetry parameters of Λ→nπ^{0} to that of Λ→pπ^{-}, ⟨α_{Λ0}⟩/⟨α_{Λ-}⟩, is determined to be 0.873±0.012_{-0.010}^{+0.011}, where the first and the second uncertainties are statistical and systematic, respectively. The ratio is smaller than unity more than 5σ, which signifies the existence of the ΔI=3/2 transition in Λ for the first time. Besides, we test for CP symmetry in Ξ^{-}→Λπ^{-} and in Λ→nπ^{0} with the best precision to date.

Observation of D_{s}^{+}→η^{'}μ^{+}ν_{μ}, Precision Test of Lepton Flavor Universality with D_{s}^{+}→η^{(')}l^{+}ν_{l}, and First Measurements of D_{s}^{+}→η^{(')}μ^{+}ν_{μ} Decay Dynamics

By analyzing 7.33  fb^{-1} of e^{+}e^{-} annihilation data collected at center-of-mass energies between 4.128 and 4.226 GeV with the BESIII detector, we report the observation of the semileptonic decay D_{s}^{+}→η^{'}μ^{+}ν_{μ}, with a statistical significance larger than 10σ, and the measurements of the D_{s}^{+}→ημ^{+}ν_{μ} and D_{s}^{+}→η^{'}μ^{+}ν_{μ} decay dynamics for the first time. The branching fractions of D_{s}^{+}→ημ^{+}ν_{μ} and D_{s}^{+}→η^{'}μ^{+}ν_{μ} are determined to be (2.235±0.051_{stat}±0.052_{syst})% and (0.801±0.055_{stat}±0.028_{syst})%, respectively, with precision improved by factors of 6.0 and 6.6 compared to the previous best measurements. Combined with the results for the decays D_{s}^{+}→ηe^{+}ν_{e} and D_{s}^{+}→η^{'}e^{+}ν_{e}, the ratios of the decay widths are examined both inclusively and in several ℓ^{+}ν_{ℓ} four-momentum transfer ranges. No evidence for lepton flavor universality violation is found within the current statistics. The products of the hadronic form factors f_{+,0}^{η^{(')}}(0) and the c→s Cabibbo-Kobayashi-Maskawa matrix element |V_{cs}| are determined. The results based on the two-parameter series expansion are f_{+,0}^{η}(0)|V_{cs}|=0.452±0.010_{stat}±0.007_{syst} and f_{+,0}^{η^{'}}(0)|V_{cs}|=0.504±0.037_{stat}±0.012_{syst}, which help to constrain present models on f_{+,0}^{η^{(')}}(0). The forward-backward asymmetries are determined to be ⟨A_{FB}^{η}⟩=-0.059±0.031_{stat}±0.005_{syst} and ⟨A_{FB}^{η^{'}}⟩=-0.064±0.079_{stat}±0.006_{syst} for the first time, which are consistent with the theoretical calculation.

[Expression of neutrophil extracellular traps and phagocytic functions among patients with hepatic alveolar echinococcosis]

OBJECTIVE

To investigate the expression of neutrophil extracellular traps (NETs) and phagocytic function in the peripheral blood of patients with hepatic alveolar echinococcosis (HAE), and to examine their correlations with clinical inflamma tory indicators and liver functions.

METHODS

A total of 50 patients with HAE admitted to Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qinghai University from August 2022 to June 2023 were enrolled, while 50 age- and gender-matched healthy individuals from the Centre for Healthy Examinations of the hospital during the same period served as controls. The levels of NETs markers neutrophil myeloperoxidase (MPO) and neutrophil elastase (NE) were measured using enzyme-linked immunosorbent assay (ELISA). Peripheral blood neutrophils were isolated using density gradient centrifugation, stimulated in vitro using phorbol 12-myristate 13 acetate (PMA), and the levels of MPO and citrullination histone H3 (CitH3) released by neutrophils were quantified using flow cytometry. The phagocytic functions of neutrophils were examined using flow cytometry. In addition, the correlations of MPO and NE levels with clinical inflammatory indicators and liver biochemical indicators were examined using Spearman correlation analysis among HAE patients.

RESULTS

The peripheral blood plasma MPO［(417.15 ± 76.08) ng/mL vs. (255.70 ± 80.84) ng/mL; t = 10.28, P < 0.05］, NE［(23.16 ± 6.75) ng/mL vs. (11.92 ± 3.17) ng/mL; t = 10.65, P < 0.05］and CitH3 levels［(33.93 ± 18.93) ng/mL vs. (19.52 ± 13.89) ng/mL; t = 4.34, P < 0.05］were all significantly higher among HAE patients than among healthy controls, and a lower phagocytosis rate of neutrophils was detected among HAE patients than among healthy controls［(70.85 ± 7.32)% vs. (94.04 ± 3.90)%; t = 20.18, P < 0.05］, and the ability to produce NETs by neutrophils was higher among HAE patients than among healthy controls following in vitro PMA stimulation. Pearson correlation analysis showed that the phagocytosis rate of neutrophils correlated negatively with platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), interleukin-6 (IL-6) level and C-reactive protein (CRP) level (rs = -0.515 to -0.392, all P values < 0.05), and the MPO and NE levels positively correlated with inflammatory markers NLR, PLR, CRP and IL-6 (rs = 0.333 to 0.445, all P values < 0.05) and clinical liver biochemical indicators aspartic transaminase, alanine aminotransferase, direct bilirubin and total bilirubin among HAE patients (rs = 0.290 to 0.628, all P values < 0.001).

CONCLUSIONS

Excessive formation of NETs is found among HAE patients, which affects the phagocytic ability of neutrophils and results in elevated levels of inflammatory indicators. NETs markers may be promising novel biomarkers for early diagnosis, monitoring, and severity assessment of liver disease.

Observation of Cabibbo-Suppressed Two-Body Hadronic Decays and Precision Mass Measurement of the Ω_{c}^{0} Baryon

The first observation of the singly Cabibbo-suppressed Ω_{c}^{0}→Ω^{-}K^{+} and Ω_{c}^{0}→Ξ^{-}π^{+} decays is reported, using proton-proton collision data at a center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 5.4  fb^{-1}, collected with the LHCb detector between 2016 and 2018. The branching fraction ratios are measured to be B(Ω_{c}^{0}→Ω^{-}K^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[6.08±0.51(stat)±0.40(syst)]%,B(Ω_{c}^{0}→Ξ^{-}π^{+})/B(Ω_{c}^{0}→Ω^{-}π^{+})=[15.81±0.87(stat)±0.44(syst)±0.16(ext)]%. In addition, using the Ω_{c}^{0}→Ω^{-}π^{+} decay channel, the Ω_{c}^{0} baryon mass is measured to be M(Ω_{c}^{0})=2695.28±0.07(stat)±0.27(syst)±0.30(ext)  MeV, improving the precision of the previous world average by a factor of 4.

Determination of the Σ^{+} Timelike Electromagnetic Form Factors

Based on data samples collected with the BESIII detector at the BEPCII collider, the process e^{+}e^{-}→Σ^{+}Σ[over ¯]^{-} is studied at center-of-mass energies sqrt[s]=2.3960, 2.6454, and 2.9000 GeV. Using a fully differential angular description of the final state particles, both the relative magnitude and phase information of the Σ^{+} electromagnetic form factors in the timelike region are extracted. The relative phase between the electric and magnetic form factors is determined to be sinΔΦ=-0.67±0.29(stat)±0.18(syst) at sqrt[s]=2.3960  GeV, ΔΦ=55°±19°(stat)±14°(syst) at sqrt[s]=2.6454  GeV, and 78°±22°(stat)±9°(syst) at sqrt[s]=2.9000  GeV. For the first time, the phase of the hyperon electromagnetic form factors is explored in a wide range of four-momentum transfer. The evolution of the phase along with four-momentum transfer is an important input for understanding its asymptotic behavior and the dynamics of baryons.

[Research on quantitative evaluation of revise requirements of Specifications of Air Sampling for Hazardous Substances Monitoring in the Workplace (GBZ 159-2004)]

Objective: To conduct quantitative evaluation on the revise requirements of Specifications of Air Sampling for Hazardous Substances Monitoring in the Workplace (GBZ 159-2004) , clarify the problems and suggestions during its implementation for improvement, and provide a basis for the revision of the standard. Methods: From April to September 2021, stratified convenient sampling method was adopted and semi-open questionnaire was used to investigate the occupational health personnel in CDC, occupational prevention and control institutes, employers, third-party technical service institutions and universitie. The entropy weight of each index and the score based on entropy weight of GBZ 159 were calculated. Spearman rank correlation analysis was used to describe the correlation between the two indexes and radar chart was drawn for comprehensive evaluation. Results: A total of 151 questionnaires were received from the respondents, of which 147 were valid, with an effective recovery rate of 97.35%, involving 29 provinces, autonomous regions and municipalities. The median G scores of the necessity and urgency of GBZ 159 revision based on entropy weight were 2.84 and 3.17, respectively, and the difference was statistically significant (M=-25.50, P<0.001) . The trend of the score G of necessity and urgency based on entropy weight was basically the same for all secondary items (r(s)=0.9998, P<0.001) , and the score G of urgency based on entropy weight was higher than that of necessity. The highest score G of necessity and urgency based on entropy weight was "3.13 long time sampling", which were 7.56 and 8.23 respectively. This was followed by "3.12 short time sampling", which were 7.19 and 7.13 respectively. Conclusion: GBZ 159 has encountered some new problems and challenges in the implementation process, and some of its technical indicators have been out of line with the actual practice of occupational health at present. These are the two items that urgently needs to be revised and improved, such as "3.13 long time sampling" and "3.12 short time sampling" and other items need to be revised and improved.

[Study on the implementation effect evaluation of Specifications of Air Sampling for Hazardous Substances Monitoring in the Workplace (GBZ 159-2004)]

Systematically evaluate the implementation of Specifications of Air Sampling for Hazardous Substances Monitoring (GBZ 159-2004) , so as to provide technical basis for the future standard revision. The semi-structured interview method was used to interview the industry experts from centers for disease control and prevention, occupational disease prevention and control hospitals/institutes, employers, third-party technical service institutions and universities, and the induction method was used to refine the topics and relevant suggestions. Some technical indicators of GBZ 159 are not suitable for the current actual work of occupational health, and need to be revised and improved urgently. The revised GBZ 159 should comply with the current situation of China's industrial development and the development of occupational health testing equipment in the new era, and improve the relevant technical requirements of sampling quality control.

Epidural Spinal Cord Stimulation for Spinal Cord Injury in Humans: A Systematic Review

(1) Background: Spinal cord injury (SCI) represents a major health challenge, often leading to significant and permanent sensorimotor and autonomic dysfunctions. This study reviews the evolving role of epidural spinal cord stimulation (eSCS) in treating chronic SCI, focusing on its efficacy and safety. The objective was to analyze how eSCS contributes to the recovery of neurological functions in SCI patients. (2) Methods: We utilized the PRISMA guidelines and performed a comprehensive search across MEDLINE/PubMed, Embase, Web of Science, and IEEE Xplore databases up until September 2023. We identified studies relevant to eSCS in SCI and extracted assessments of locomotor, cardiovascular, pulmonary, and genitourinary functions. (3) Results: A total of 64 studies encompassing 306 patients were identified. Studies investigated various stimulation devices, parameters, and rehabilitation methods. Results indicated significant improvements in motor function: 44% of patients achieved assisted or independent stepping or standing; 87% showed enhanced muscle activity; 65% experienced faster walking speeds; and 80% improved in overground walking. Additionally, eSCS led to better autonomic function, evidenced by improvements in bladder and sexual functions, airway pressures, and bowel movements. Notable adverse effects included device migration, infections, and post-implant autonomic dysreflexia, although these were infrequent. (4) Conclusion: Epidural spinal cord stimulation is emerging as an effective and generally safe treatment for chronic SCI, particularly when combined with intensive physical rehabilitation. Future research on standardized stimulation parameters and well-defined therapy regimens will optimize benefits for specific patient populations.

Improved Measurement of CP Violation Parameters in B_{s}^{0}→J/ψK^{+}K^{-} Decays in the Vicinity of the ϕ(1020) Resonance

The decay-time-dependent CP asymmetry in B_{s}^{0}→J/ψ(→μ^{+}μ^{-})K^{+}K^{-} decays is measured using proton-proton collision data, corresponding to an integrated luminosity of 6  fb^{-1}, collected with the LHCb detector at a center-of-mass energy of 13 TeV. Using a sample of approximately 349 000 B_{s}^{0} signal decays with an invariant K^{+}K^{-} mass in the vicinity of the ϕ(1020) resonance, the CP-violating phase ϕ_{s} is measured, along with the difference in decay widths of the light and heavy mass eigenstates of the B_{s}^{0}-B[over ¯]_{s}^{0} system, ΔΓ_{s}, and the difference of the average B_{s}^{0} and B^{0} meson decay widths, Γ_{s}-Γ_{d}. The values obtained are ϕ_{s}=-0.039±0.022±0.006  rad, ΔΓ_{s}=0.0845±0.0044±0.0024  ps^{-1}, and Γ_{s}-Γ_{d}=-0.0056_{-0.0015}^{+0.0013}±0.0014  ps^{-1}, where the first uncertainty is statistical and the second systematic. These are the most precise single measurements to date and are consistent with expectations based on the Standard Model and with the previous LHCb analyses of this decay. These results are combined with previous independent LHCb measurements. The phase ϕ_{s} is also measured independently for each polarization state of the K^{+}K^{-} system and shows no evidence for polarization dependence.

[Quantitative analysis of risk assessment indicators for re-introduction of imported malaria in China]

OBJECTIVE

To quantitatively analyze the risk indicators of re-introduction of imported malaria in China and their weighting coefficients, so as to investigate the difference in the contribution of risk indicators included in the current risk assessment framework for re-introduction of imported malaria in China to the risk assessment of re-introduction of imported malaria.

METHODS

Publications pertaining to the risk assessment framework for re-introduction of imported malaria in China that reported the risk indicators and their weighting coefficients were retrieved in PubMed, Web of Science, CNKI, Wanfang Data, and VIP with terms of "malaria", "re-introduction/re-transmission/re-establishment", "risk assessment/risk evaluation/risk prediction" from the inception of the database through 3 August 2023, and literature search was performed in Google Scholar to ensure the comprehensiveness of the retrieval. Basic characteristics of included studies were extracted using pre-designed information extraction forms by two investigators, and data pertaining to risk indicators of re-introduction of imported malaria were cross-checked by these two investigators. The risk indicators included in the risk assessment framework for re-introduction of imported malaria in China and their weighting coefficients were visualized with the Nightingale's rose diagrams using the software R 4.2.1, and the importance of risk indictors was evaluated with the frequency of risk indicators included in the risk assessment framework and the ranking of weighting coefficients of risk indicators. In addition, the capability of risk indicators screened by different weighting methods was compared by calculating the ratio of the maximum to the minimum of the weighting coefficients of the risk indicators screened by different weighting methods.

RESULTS

A total of 2 138 publications were retrieved, and following removal of duplications and screening, a total of 8 publications were included in the final analysis. In these 8 studies, 8 risk assessment frameworks for re-introduction of imported malaria in China and 52 risk indicators of re-introduction of imported malaria were reported, in which number of imported malaria cases (n = 8) and species of malaria vectors were more frequently included in the risk assessment frameworks (n = 8), followed by species of imported malaria parasites (n = 6) and population density of local malaria vectors (n = 6), and species of local malaria vectors (n = 6), number of imported malaria cases (n = 5) and species of imported malaria parasites had the three highest weighting coefficients (n = 4). The weighting methods included expert scoring method, combination of expert scoring method and analytic hierarchy process, and combination of expert scoring method and entropy weight method in these 8 studies, and the ratios of the maximum to the minimum of the weighting coefficients of the risk indicators screened by the expert scoring method were 1.143 to 2.241, while the ratios of the maximum to the minimum of the weighting coefficients of the risk indicators screened by combination of the expert scoring method and analytic hierarchy process were 34.970 to 162.000.

CONCLUSIONS

Number of imported malaria cases, species of imported malaria parasites, species of local malaria vectors and population density of local malaria vectors are core indicators in the current risk assessment framework for re-introduction of imported malaria in China. Combination of the expert scoring method and analytic hierarchy process is superior to the expert scoring method alone for weighting the risk indicators.

First Measurement of the Decay Asymmetry in the Pure W-Boson-Exchange Decay Λ_{c}^{+}→Ξ^{0}K^{+}

Based on 4.4  fb^{-1} of e^{+}e^{-} annihilation data collected at the center-of-mass energies between 4.60 and 4.70 GeV with the BESIII detector at the BEPCII collider, the pure W-boson-exchange decay Λ_{c}^{+}→Ξ^{0}K^{+} is studied with a full angular analysis. The corresponding decay asymmetry is measured for the first time to be α_{Ξ^{0}K^{+}}=0.01±0.16(stat)±0.03(syst). This result reflects the noninterference effect between the S- and P-wave amplitudes. The phase shift between S- and P-wave amplitudes has two solutions, which are δ_{p}-δ_{s}=-1.55±0.25(stat)±0.05(syst)  rad or 1.59±0.25(stat)±0.05(syst)  rad.

[Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia]

Objective: To evaluate the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with secondary acute myeloid leukemia (sAML) . Methods: In this multicenter, retrospective clinical study, adult patients aged ≥18 years who underwent allo-HSCT for sAML at four centers of the Zhejiang Hematopoietic Stem Cell Transplantation Collaborative Group from January 2014 to November 2022 were included, and the efficacy and prognostic factors of allo-HSCT were analyzed. Results: A total of 95 patients were enrolled; 66 (69.5%) had myelodysplastic syndrome-acute myeloid leukemia (MDS-AML) , 4 (4.2%) had MDS/MPN-AML, and 25 (26.3%) had therapy-related AML (tAML) . The 3-year CIR, LFS, and overall survival (OS) rates were 18.6% (95% CI 10.2%-27.0%) , 70.6% (95% CI 60.8%-80.4%) , and 73.3% (95% CI 63.9%-82.7%) , respectively. The 3-year CIRs of the M-AML group (including MDS-AML and MDS/MPN-AML) and the tAML group were 20.0% and 16.4%, respectively (P=0.430) . The 3-year LFSs were 68.3% and 75.4%, respectively (P=0.176) . The 3-year OS rates were 69.7% and 75.4%, respectively (P=0.233) . The 3-year CIRs of the groups with and without TP53 mutations were 60.0% and 13.7%, respectively (P=0.003) ; the 3-year LFSs were 20.0% and 76.5%, respectively (P=0.002) ; and the 3-year OS rates were 40.0% and 77.6%, respectively (P=0.002) . According to European LeukmiaNet 2022 (ELN2022) risk stratification, the 3-year CIRs of patients in the low-, intermediate-, and high-risk groups were 8.3%, 17.8%, and 22.6%, respectively (P=0.639) . The three-year LFSs were 91.7%, 69.5%, and 65.6%, respectively (P=0.268) . The 3-year OS rates were 91.7%, 71.4%, and 70.1%, respectively (P=0.314) . Multivariate analysis revealed that advanced disease at allo-HSCT and TP53 mutations were independent risk factors for CIR, LFS, and OS. Conclusion: There was no significant difference in the prognosis of patients who underwent allo-HSCT among the MDS-AML, MDS/MPN-AML, and tAML groups. Advanced disease at transplantation and TP53 mutations were poor prognostic factors. ELN2022 risk stratification had limited value for predicting the prognosis of patients with sAML following allo-HSCT.

Measurement of CP Violation in B^{0}→ψ(→ℓ^{+}ℓ^{-})K_{S}^{0}(→π^{+}π^{-}) Decays

A measurement of time-dependent CP violation in the decays of B^{0} and B[over ¯]^{0} mesons to the final states J/ψ(→μ^{+}μ^{-})K_{S}^{0}, ψ(2S)(→μ^{+}μ^{-})K_{S}^{0} and J/ψ(→e^{+}e^{-})K_{S}^{0} with K_{S}^{0}→π^{+}π^{-} is presented. The data correspond to an integrated luminosity of 6  fb^{-1} collected at a center-of-mass energy of sqrt[s]=13  TeV with the LHCb detector. The CP-violation parameters are measured to be S_{ψK_{S}^{0}}=0.717±0.013(stat)±0.008(syst) and C_{ψK_{S}^{0}}=0.008±0.012(stat)±0.003(syst). This measurement of S_{ψK_{S}^{0}} represents the most precise single measurement of the CKM angle β to date and is more precise than the current world average. In addition, measurements of the CP-violation parameters of the individual channels are reported and a combination with the LHCb Run 1 measurements is performed.

[Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia]

Objective: To analyze the clinical characteristics and prognosis of patients with infant acute lymphoblastic leukemia (IALL). Methods: A retrospective cohort study.Clinical data, treatment and prognosis of 28 cases of IALL who have been treated at Beijing Children's Hospital, Capital Medical University and Baoding Children's Hospital from October 2013 to May 2023 were analyzed retrospectively. Based on the results of fluorescence in situ hybridization (FISH), all patients were divided into KMT2A gene rearrangement (KMT2A-R) positive group and KMT2A-R negative group. The prognosis of two groups were compared. Kaplan-Meier method and Log-Rank test were used to analyze the survival of the patients. Results: Among 28 cases of IALL, there were 10 males and 18 females, with the onset age of 10.9 (9.4,11.8) months. In terms of immune classification, 25 cases were B-ALL (89%), while the remaining 3 cases were T-ALL (11%). Most infant B-ALL showed pro-B lymphocyte phenotype (16/25,64%). A total of 22 cases (79%) obtained chromosome karyotype results, of which 7 were normal karyotypes, no complex karyotypes and 15 were abnormal karyotypes were found. Among abnormal karyotypes, there were 4 cases of t (9; 11), 2 cases of t (4; 11), 2 cases of t (11; 19), 1 case of t (1; 11) and 6 cases of other abnormal karyotypes. A total of 19 cases (68%) were positive for KMT2A-R detected by FISH. The KMT2A fusion gene was detected by real-time PCR in 16 cases (57%). A total of 24 patients completed standardized induction chemotherapy and were able to undergo efficacy evaluation, 23 cases (96%) achieved complete remission through induction chemotherapy, 4 cases (17%) died of relapse. The 5-year event free survival rate (EFS) was (46±13)%, and the 5-year overall survival rate (OS) was (73±10)%.The survival time was 31.3 (3.3, 62.5) months. There was no significant statistical difference in 5-year EFS ((46±14)% vs. (61±18)%) and 5-year OS ((64±13)% vs. (86±13)%) between the KMT2A-R positive group (15 cases) and the KMT2A-R negative group (9 cases) (χ2=1.88, 1.47, P=0.170, 0.224). Conclusions: Most IALL patients were accompanied by KMT2A-R. They had poor tolerance to traditional chemotherapy, the relapse rate during treatment was high and the prognosis was poor.

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

BACKGROUND

Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce progression of chronic kidney disease and the risk of cardiovascular morbidity and mortality in a wide range of patients. However, their effects on kidney disease progression in some patients with chronic kidney disease are unclear because few clinical kidney outcomes occurred among such patients in the completed trials. In particular, some guidelines stratify their level of recommendation about who should be treated with SGLT2 inhibitors based on diabetes status and albuminuria. We aimed to assess the effects of empagliflozin on progression of chronic kidney disease both overall and among specific types of participants in the EMPA-KIDNEY trial.

METHODS

EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA), and included individuals aged 18 years or older with an estimated glomerular filtration rate (eGFR) of 20 to less than 45 mL/min per 1·73 m2, or with an eGFR of 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher. We explored the effects of 10 mg oral empagliflozin once daily versus placebo on the annualised rate of change in estimated glomerular filtration rate (eGFR slope), a tertiary outcome. We studied the acute slope (from randomisation to 2 months) and chronic slope (from 2 months onwards) separately, using shared parameter models to estimate the latter. Analyses were done in all randomly assigned participants by intention to treat. EMPA-KIDNEY is registered at ClinicalTrials.gov, NCT03594110.

FINDINGS

Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and then followed up for a median of 2·0 years (IQR 1·5-2·4). Prespecified subgroups of eGFR included 2282 (34·5%) participants with an eGFR of less than 30 mL/min per 1·73 m2, 2928 (44·3%) with an eGFR of 30 to less than 45 mL/min per 1·73 m2, and 1399 (21·2%) with an eGFR 45 mL/min per 1·73 m2 or higher. Prespecified subgroups of uACR included 1328 (20·1%) with a uACR of less than 30 mg/g, 1864 (28·2%) with a uACR of 30 to 300 mg/g, and 3417 (51·7%) with a uACR of more than 300 mg/g. Overall, allocation to empagliflozin caused an acute 2·12 mL/min per 1·73 m2 (95% CI 1·83-2·41) reduction in eGFR, equivalent to a 6% (5-6) dip in the first 2 months. After this, it halved the chronic slope from -2·75 to -1·37 mL/min per 1·73 m2 per year (relative difference 50%, 95% CI 42-58). The absolute and relative benefits of empagliflozin on the magnitude of the chronic slope varied significantly depending on diabetes status and baseline levels of eGFR and uACR. In particular, the absolute difference in chronic slopes was lower in patients with lower baseline uACR, but because this group progressed more slowly than those with higher uACR, this translated to a larger relative difference in chronic slopes in this group (86% [36-136] reduction in the chronic slope among those with baseline uACR <30 mg/g compared with a 29% [19-38] reduction for those with baseline uACR ≥2000 mg/g; ptrend<0·0001).

INTERPRETATION

Empagliflozin slowed the rate of progression of chronic kidney disease among all types of participant in the EMPA-KIDNEY trial, including those with little albuminuria. Albuminuria alone should not be used to determine whether to treat with an SGLT2 inhibitor.

FUNDING

Boehringer Ingelheim and Eli Lilly.

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

BACKGROUND

The EMPA-KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population.

METHODS

EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110.

FINDINGS

Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5-2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62-0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The between-group difference in chronic eGFR slopes (ie, from 2 months to final follow-up) was 1·37 mL/min per 1·73 m2 per year (95% CI 1·16-1·59), representing a 50% (42-58) reduction in the rate of chronic eGFR decline. This relative effect of empagliflozin on chronic eGFR slope was similar in analyses by different primary kidney diseases, including in explorations by type of glomerular disease and diabetes (p values for heterogeneity all >0·1).

INTERPRETATION

In a broad range of patients with chronic kidney disease at risk of progression, including a wide range of non-diabetic causes of chronic kidney disease, empagliflozin reduced risk of kidney disease progression. Relative effect sizes were broadly similar irrespective of the cause of primary kidney disease, suggesting that SGLT2 inhibitors should be part of a standard of care to minimise risk of kidney failure in chronic kidney disease.

FUNDING

Boehringer Ingelheim, Eli Lilly, and UK Medical Research Council.

[Daratumumab maintenance after autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma]

Objective: This study aimed to evaluate the efficacy and safety of daratumumab as a maintenance treatment after autologous hematopoietic stem cell transplantation (auto-HSCT) in patients with newly diagnosed multiple myeloma (NDMM) . Methods: The clinical data, hematological and renal response, and safety of 15 post-transplant patients with NDMM who had received daratumumab maintenance between May 1, 2022 and June 30, 2023 were retrospectively analyzed. Results: Fifteen patients (11 males and 4 females) with a median age of 58 (41-72) years were included. Thirteen patients did not receive daratumumab during induction therapy and auto-HSCT, 6 patients had renal impairment, and nine patients had high-risk cytogenetics. The median infusion of daratumumab was 12 (6-17) times, and the median duration of maintenance was 6 (1.5-12) months. The treatment efficacy was evaluated in all 15 patients, and daratumumab maintenance therapy increased the rate of stringent complete response from 40% to 60%. The renal response rate and median estimated glomerular filtration rate of six patients with RI-NDMM were also improved. During daratumumab maintenance therapy, the most common hematological grade 3 adverse event (AE) was lymphopenia [4 of 15 patients (26.67%) ], whereas the most common nonhematologic AEs were infusion-related reactions [7 of 15 patients (46.67%) ] and grade 3 pneumonia [5 of 15 patients (33.33%) ]. The five patients with pneumonia were daratumumab naive [5 of 13 patients (38.46%) ], with a median of 8 (6-10) infusions. Among them, the chest computed tomography of three patients showed interstitial infiltrates, and treatment with methylprednisolone was effective. With a median follow-up of 12 months, the 1-year overall survival rate was 93.33%, and only one patient died (which was not related to daratumumab treatment) . Conclusions: Daratumumab was safe and effective as a maintenance agent for post-auto-HSCT patients with NDMM, and AEs were controllable. The most common nonhematologic AE was grade 3 pneumonia, and a less dose-intense maintenance regimen for the first 8 weeks could reduce the incidence of pneumonia.

[Attitude toward sexual health education and its correlates among community-based older adults in Shanghai]

Objective: To understand the attitudes toward sexual health education and its correlates among community-based older adults in Shanghai, China. Methods: From June 2020 to December 2022, a cross-sectional survey was conducted among community residents aged ≥50 in Shanghai through multi-stage sampling. The estimated sample size was 735. The questionnaire included sociodemographic characteristics, health characteristics, and history of sexual health education. The multivariable logistic regression model was used to assess the correlates of attitudes toward sexual health education among community-based older adults. Results: A total of 824 participants (489 males and 335 females) with age of (65.1±8.1) years were included, whose main age distribution was 60-69 years (45.3%). The prevalence of supporting sexual health education among older adults was 49.4% (45.2% of men and 55.5% of women). Males (aOR=0.61, 95%CI: 0.44-0.83), aged 70 years and older (aOR=0.62, 95%CI: 0.40-0.94), urban residents (aOR= 2.54, 95%CI: 1.81-3.58), self-reported very good or excellent health status (aOR=1.64,95%CI: 1.04-2.58), having depressive symptoms (aOR=0.37,95%CI: 0.15-0.85), and having a history of sexual health education (aOR=8.64,95%CI: 4.62-17.70) were associated with their attitude toward sexual health education. Conclusions: The proportion of community-based older adults in Shanghai who support sexual health education was not high. Their attitudes toward sexual health education were associated with their self-reported health status, depressive symptoms, and history of sex education. Health professionals and institutions should focus on community-based older adults with key characteristics and tailor interventions to promote the willingness to receive sexual health education among older adults in China and to promote the popularity of sexual health education in this population.

[Sexually active status and its correlates among community-based older adults in Tianjin]

Objective: To understand the sexually active status among community-based older adults aged ≥50 years in Tianjin, China, and to explore the potential correlates. Methods: A cross-sectional survey using multistage sampling among community-based older adults aged ≥50 was conducted between June 2020 and December 2022. The estimated sample size was 735. The survey collected questionnaire information through face-to-face interviews with investigators, including sociodemographic, health, and sexual lifestyle characteristics. The multivariable logistic regression model was used to assess correlates of sexually active status. Results: A total of 776 study participants (510 males and 266 females) were included, whose major age distribution was 50-59 years (45.9%). The overall sexual activity prevalence of the participants was 45.6%. Older age (60-69: aOR=0.67, 95%CI: 0.45-0.99; ≥70: aOR=0.12, 95%CI: 0.07-0.21), being male (aOR=1.93, 95%CI: 1.32-2.82), living in urban area (aOR=0.18, 95%CI: 0.12-0.28), living with spouse/married (aOR=2.80, 95%CI: 1.41-5.58), living alone (aOR=0.51, 95%CI: 0.27-0.96), having difficulty climbing stairs or walking (aOR=0.55, 95%CI: 0.31-0.97), having chronic diseases (one chronic disease: aOR=0.55, 95%CI: 0.36-0.85; two or more chronic diseases: aOR=0.53, 95%CI: 0.33-0.84) were associated with sexually active status among older adults. Conclusions: Many community-based older adults remained sexually active. There was an association between physical health and sexually active status among community-based older adults. Incorporating sexual health services into healthcare services for community-based older adults could be advocated, with a concurrent emphasis on enhancing the awareness and competence of providing sexual health services among community-based healthcare workers.

[Utilization of sexual and reproductive health services and its correlates among community- based older adults in Chongqing]

Objective: To investigate the utilization of sexual health services among community-based older adults in Chongqing and explore its potential correlates. Methods: A cross-sectional survey using multistage sampling among community-based older adults aged ≥50 years was conducted in Chongqing between June 2020 and December 2022. A questionnaire including information on demographic characteristics, general health, sexual health status, and sexual health services utilization was collected. Sexual health and reproductive services utilization was defined as having ever been tested for human immunodeficiency virus (HIV), or having had a male/gynecological reproductive health examination in the past year. Logistic regression was used to examine the correlates of the utilization of sexual health services. Results: A total of 794 community-based older adults participated in the study (482 were male, and 312 were female). The mean age was (62.8±8.2) years. The proportion of HIV testing was 18.0%, and the proportion of reproductive health examination was 10.1% among community-based older adults. The results of multivariate logistic regression analysis showed that the age group of 60-69 years (aOR=0.37, 95%CI: 0.18-0.76), female (aOR=11.34, 95%CI: 5.71-22.52), monthly income ≥5 000 yuan (aOR=3.05, 95%CI: 1.01-9.27), being sexual activity (aOR=4.99, 95%CI: 2.23-11.15) was significantly associated with had a reproductive health examination in the past year. Conclusions: The proportion of sexual health services utilization among older adults was low. Older sexual health education should be further strengthened, the close relationship between older adults should be correctly guided and dealt with, and the sexual health services suitable for the older population should be formulated.

[Condom use and its correlates among community-based older adults in Chongqing]

Objective: To understand the current status of condom use and its correlates among community-based older adults in Chongqing, China. Methods: Cross-sectional study based on a multistage sampling method was conducted in Chongqing from June 2020 to December 2022. The estimated sample size was 735. Through face-to-face interviews, the investigators collected the sociodemographic characteristics, sexual behavior characteristics, awareness of AIDS prevention knowledge, etc. A multivariable logistic regression model was used to explore the correlates of condom use during the last sexual behavior among the participants. Results: A total of 761 participants were included in this study, with 476 males and 285 females, whose average age was (63.8±8.2) years old, mainly in the age group of 60-69 years (44.5%). Among the participants, the rate of condom use during the last sexual behavior was 9.7%. The multivariable logistic regression analysis indicated that correlates of condom use during the last sexual behavior included urban household registration (aOR=2.34, 95%CI: 1.12-4.89), monthly income of 1 000-4 999 Yuan, and 5 000 Yuan and above (aOR=4.49, 95%CI: 1.31-15.41; aOR=16.33, 95%CI: 4.30-62.00), self-assessed sexual behavior risk as very risky/relatively risky (aOR=3.97, 95%CI: 1.40-11.31), awareness of AIDS prevention knowledge (aOR=0.36, 95%CI: 0.21-0.62). Conclusions: The rate of condom use among community-based older adults in Chongqing is low. Comprehensive intervention measures should be taken in combination with the characteristics and needs of community-based older adults to improve awareness of AIDS prevention knowledge and perception of AIDS risk and promote condom use among this population.

Test of CP Symmetry in Hyperon to Neutron Decays

The quantum entangled J/ψ→Σ^{+}Σ[over ¯]^{-} pairs from (1.0087±0.0044)×10^{10}  J/ψ events taken by the BESIII detector are used to study the nonleptonic two-body weak decays Σ^{+}→nπ^{+} and Σ[over ¯]^{-}→n[over ¯]π^{-}. The CP-odd weak decay parameters of the decays Σ^{+}→nπ^{+} (α_{+}) and Σ[over ¯]^{-}→n[over ¯]π^{-} (α[over ¯]_{-}) are determined to be 0.0481±0.0031_{stat}±0.0019_{syst} and -0.0565±0.0047_{stat}±0.0022_{syst}, respectively. The decay parameter α[over ¯]_{-} is measured for the first time, and the accuracy of α_{+} is improved by a factor of 4 compared to the previous results. The simultaneously determined decay parameters allow the first precision CP symmetry test for any hyperon decay with a neutron in the final state with the measurement of A_{CP}=(α_{+}+α[over ¯]_{-})/(α_{+}-α[over ¯]_{-})=-0.080±0.052_{stat}±0.028_{syst}. Assuming CP conservation, the average decay parameter is determined as ⟨α_{+}⟩=(α_{+}-α[over ¯]_{-})/2=-0.0506±0.0026_{stat}±0.0019_{syst}, while the ratios α_{+}/α_{0} and α[over ¯]_{-}/α[over ¯]_{0} are -0.0490±0.0032_{stat}±0.0021_{syst} and -0.0571±0.0053_{stat}±0.0032_{syst}, where α_{0} and α[over ¯]_{0} are the decay parameters of the decays Σ^{+}→pπ^{0} and Σ[over ¯]^{-}→p[over ¯]π^{0}, respectively.

Measurement of Energy-Dependent Pair-Production Cross Section and Electromagnetic Form Factors of a Charmed Baryon

We study the process e^{+}e^{-}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} at twelve center-of-mass energies from 4.6119 to 4.9509 GeV using data samples collected by the BESIII detector at the BEPCII collider. The Born cross sections and effective form factors (|G_{eff}|) are determined with unprecedented precision after combining the single and double-tag methods based on the decay process Λ_{c}^{+}→pK^{-}π^{+}. Flat cross sections around 4.63 GeV are obtained and no indication of the resonant structure Y(4630), as reported by Belle, is found. In addition, no oscillatory behavior is discerned in the |G_{eff}| energy dependence of Λ_{c}^{+}, in contrast to what is seen for the proton and neutron cases. Analyzing the cross section together with the polar-angle distribution of the Λ_{c}^{+} baryon at each energy point, the moduli of electric and magnetic form factors (|G_{E}| and |G_{M}|) are extracted and separated. For the first time, the energy dependence of the form factor ratio |G_{E}/G_{M}| is observed, which can be well described by an oscillatory function.

[A single-center study on the oncological outcomes of active surveillance of thyroid nodules measuring≤1 cm with highly suspicious ultrasound features]

Objective: To investigate the oncological outcomes of active surveillance (AS) in patients showing thyroid nodules measuring≤1 cm with highly suspicious ultrasound features. Methods: A prospective single-center cohort study. A total of 534 patients with highly suspicious thyroid nodules (2015 American Thyroid Association Nodule Sonographic Patterns and Risk of Malignancy: High Suspicion) were enrolled in this study, the patients received AS at Peking Union Medical College Hospital between January 2017 and November 2022 to assess oncological outcomes (disease progression, recurrence/metastasis rate, etc). The patients were followed up every 6 months for physical examination and neck ultrasound examination. And the value of tumor volume changes in evaluating tumor enlargement was explored too. Results: There were 413 females and 121 males in this cohort, with a mean age of (42.6±11.8) years. During a median follow-up period of 45.6 months (ranged from 3.5 to 176.0 months), disease progression occurred in 26 patients (4.9%) with highly suspicious thyroid nodules, characterized by a minimum 3-mm increase in tumor diameter in 19 patients (3.6%) and lymph node metastases in 7 patients (1.3%). Forty-seven (8.8%) patients opted for delayed surgery, with 29 patients due to a change in preference. There was no significant differences in pathologic and follow-up outcomes between patients with disease progression and preference change. Patients aged≤40 years had a higher cumulative incidence of 5-year disease progression than those aged>40 years (4.9% vs 1.9%, P=0.060). No patients experienced distant metastases or deaths. Among the 595 high-risk thyroid nodules with continuous volume assessment results and an increase in nodule diameter of less than 3 mm (including all high-risk nodules in patients with single or multiple nodules), 184 (30.9%) and 79 (13.3%) nodules exhibited volume increases of more than 50% and 100%, respectively, in multiple measurements. Among the nodules with volume changes exceeding 50% and 100%, the proportion of nodules with a baseline tumor diameter of≤0.5 cm was significantly higher than those with a diameter of>0.5 cm, at 69.0% vs 31.0% (P<0.001) and 77.2% vs 22.8% (P<0.001), respectively. Conclusions: Active surveillance in patients with highly suspicious subcentimeter thyroid nodules has good short-term oncological outcomes and can be considered a safe alternative to surgery. Due to the large variability in the measurement results of tumor volume, it is not suitable as an indicator for evaluating tumor enlargement.

Observation of New Baryons in the Ξ_{b}^{-}π^{+}π^{-} and Ξ_{b}^{0}π^{+}π^{-} Systems

The first observation and study of two new baryonic structures in the final state Ξ_{b}^{0}π^{+}π^{-} and the confirmation of the Ξ_{b}(6100)^{-} state in the Ξ_{b}^{-}π^{+}π^{-} decay mode are reported using proton-proton collision data collected by the LHCb experiment, corresponding to an integrated luminosity of 9  fb^{-1}. In addition, the properties of the known Ξ_{b}^{*0}, Ξ_{b}^{'-} and Ξ_{b}^{*-} resonances are measured with improved precision. The new decay mode of the Ξ_{b}^{0} baryon to the Ξ_{c}^{+} π^{-} π^{+} π^{-} final state is observed and exploited for the first time in these measurements.

Precision Measurement of CP Violation in the Penguin-Mediated Decay B_{s}^{0}→ϕϕ

A flavor-tagged time-dependent angular analysis of the decay B_{s}^{0}→ϕϕ is performed using pp collision data collected by the LHCb experiment at the center-of-mass energy of 13 TeV, corresponding to an integrated luminosity of 6  fb^{-1}. The CP-violating phase and direct CP-violation parameter are measured to be ϕ_{s}^{ss[over ¯]s}=-0.042±0.075±0.009  rad and |λ|=1.004±0.030±0.009, respectively, assuming the same values for all polarization states of the ϕϕ system. In these results, the first uncertainties are statistical and the second systematic. These parameters are also determined separately for each polarization state, showing no evidence for polarization dependence. The results are combined with previous LHCb measurements using pp collisions at center-of-mass energies of 7 and 8 TeV, yielding ϕ_{s}^{ss[over ¯]s}=-0.074±0.069  rad and |λ|=1.009±0.030. This is the most precise study of time-dependent CP violation in a penguin-dominated B meson decay. The results are consistent with CP symmetry and with the standard model predictions.

[Efficacy and safety analysis of the zanubrutinib-based bridging regimen in chimeric antigen receptor T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma]

Objective: To further elucidate the clinical efficacy and safety of a combination regimen based on the BTK inhibitor zebutanil bridging CD19 Chimeric antigen receptor T cells (CAR-T cells) in the treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) . Methods: Twenty-one patients with high-risk r/r DLBCL were treated with a zanubrutinib-based regimen bridging CAR-T between June 2020 and June 2023 at the Department of Hematology, Tongji Hospital, Tongji University and the Second Affiliated Hospital of Zhejiang University, and the efficacy and safety were retrospectively analyzed. Results: All 21 patients were enrolled, and the median age was 57 years (range: 38-76). Fourteen patients (66.7%) had an eastern cooperative oncology group performance status score (ECOG score) of ≥2. Eighteen patients (85.7%) had an international prognostic index (IPI) score of ≥3. Three patients (14.3%) had an IPI score of 2 but had extranodal infiltration. Fourteen patients (66.7%) had double-expression of DLBCL and seven (33.3%) had TP53 mutations. With a median follow-up of 24.8 (95% CI 17.0-31.6) months, the objective response rate was 81.0%, and 11 patients (52.4%) achieved complete remission. The median progression-free survival (PFS) was 12.8 months, and the median overall survival (OS) was not reached. The 1-year PFS rate was 52.4% (95% CI 29.8% -74.3%), and the 1-year OS rate was 80.1% (95% CI 58.1% -94.6%). Moreover, 18 patients (85.7%) had grade 1-2 cytokine-release syndrome, and two patients (9.5%) had grade 1 immune effector cell-associated neurotoxicity syndrome. Conclusion: Zanubrutinib-based combination bridging regimen of CAR-T therapy for r/r DLBCL has high efficacy and demonstrated a good safety profile.

Determination of Spin-Parity Quantum Numbers for the Narrow Structure near the pΛ[over ¯] Threshold in e^{+}e^{-}→pK^{-}Λ[over ¯]+c.c

A narrow structure in the pΛ[over ¯] system near the mass threshold, named as X(2085), is observed in the process e^{+}e^{-}→pK^{-}Λ[over ¯] with a statistical significance greater than 20σ. Its spin and parity are determined for the first time to be J^{P}=1^{+} in an amplitude analysis, with a statistical significance greater than 5σ over other quantum numbers (0^{-},1^{-} and 2^{+}). The pole positions of X(2085) are measured to be M_{pole}=(2084_{-2}^{+4}±9)  MeV and Γ_{pole}=(58_{-3}^{+4}±25)  MeV, where the first uncertainties are statistical and the second ones are systematic. The analysis is based on the study of the process e^{+}e^{-}→pK^{-}Λ[over ¯] and uses the data samples collected with the BESIII detector at the center-of-mass energies sqrt[s]=4.008, 4.178, 4.226, 4.258, 4.416, and 4.682 GeV with a total integrated luminosity of 8.35  fb^{-1}.

Measurement of the Λ_{b}^{0}→Λ(1520)μ^{+}μ^{-} Differential Branching Fraction

The branching fraction of the rare decay Λ_{b}^{0}→Λ(1520)μ^{+}μ^{-} is measured for the first time, in the squared dimuon mass intervals q^{2}, excluding the J/ψ and ψ(2S) regions. The data sample analyzed was collected by the LHCb experiment at center-of-mass energies of 7, 8, and 13 TeV, corresponding to a total integrated luminosity of 9  fb^{-1}. The result in the highest q^{2} interval, q^{2}>15.0  GeV^{2}/c^{4}, where theoretical predictions have the smallest model dependence, agrees with the predictions.

Precise Measurement of the e^{+}e^{-}→D_{s}^{*+}D_{s}^{*-} Cross Sections at Center-of-Mass Energies from Threshold to 4.95 GeV

The process e^{+}e^{-}→D_{s}^{*+}D_{s}^{*-} is studied with a semi-inclusive method using data samples at center-of-mass energies from threshold to 4.95 GeV collected with the BESIII detector operating at the Beijing Electron Positron Collider. The Born cross sections of the process are measured for the first time with high precision in this energy region. Two resonance structures are observed in the energy-dependent cross sections around 4.2 and 4.4 GeV. By fitting the cross sections with a coherent sum of three Breit-Wigner amplitudes and one phase-space amplitude, the two significant structures are assigned masses of (4186.8±8.7±30) and (4414.6±3.4±6.1)  MeV/c^{2}, widths of (55±15±53) and (122.5±7.5±8.1)  MeV, where the first errors are statistical and the second ones are systematic. The inclusion of a third Breit-Wigner amplitude is necessary to describe a structure around 4.79 GeV.

[Association of category of dietary intake and physical activity with the risk of mortality in patients with type 2 diabetes mellitus: a prospective cohort study]

Objective: To investigate the association between dietary intake and physical activity category and their combined effects on all-cause and cause-specific mortality risk in patients with type 2 diabetes mellitus (T2DM). Methods: Between December 2013 and December 2021, a prospective cohort study was conducted on 19 863 T2DM patients in Changshu City, Qingjiangpu District (formerly Qinghe District), and Huai'an District, included in the national basic health service management. Information on deaths and underlying causes of death was obtained from the Jiangsu Provincial CDC and Prevention Death Surveillance System. Cox proportional hazards models were used to estimate the intensity of associations between dietary intake, physical activity, and their combined effects with all-cause and cause-specific mortality in patients with T2DM. Results: As of December 31, 2021, the research subjects had been followed up for 150 283 person-years, with a median follow-up time of 8.15 years. During the follow-up period, 3 293 people died, including 1 124 deaths from cardiovascular disease (CVD) and 875 deaths from cancer. Cox regression analysis showed that compared with the population of 0-1 recommended food group, those having more than five recommended food groups had a 19% lower risk of all-cause mortality [hazard ratio (HR)=0.81, 95%CI: 0.70-0.94] and a 33% lower risk of all-cause mortality (HR=0.67, 95%CI: 0.52-0.87). Compared with the T2DM population in the physical activity Q1 group, the risk of all-cause mortality, CVD mortality, and cancer mortality among the physical activity Q4 group reduced by 50% (HR=0.50, 95%CI: 0.45-0.56), 50% (HR=0.50, 95%CI: 0.41-0.61), and 27% (HR=0.73, 95%CI: 0.60-0.88), respectively. The combined effect showed that compared with the population in the intake of food categories 0-2 and low physical activity groups, the risk of all-cause, CVD mortality, and cancer mortality in the intake of food categories 4-9 and high physical activity groups reduced by 55% (HR=0.45, 95%CI: 0.38-0.53), 56% (HR=0.44, 95%CI: 0.32-0.59), and 40% (HR=0.60, 95%CI: 0.44-0.82), respectively. Conclusion: Type of dietary intake, physical activity, and their combined effects are associated with a reduced mortality risk in patients with T2DM.

First Experimental Study of the Purely Leptonic Decay D_{s}^{*+}→e^{+}ν_{e}

Using 7.33  fb^{-1} of e^{+}e^{-} collision data taken with the BESIII detector at the BEPCII collider, we report the first experimental study of the purely leptonic decay D_{s}^{*+}→e^{+}ν_{e}. Our data contain a signal of this decay with a statistical significance of 2.9σ. The branching fraction of D_{s}^{*+}→e^{+}ν_{e} is measured to be (2.1_{-0.9_{stat}}^{+1.2}±0.2_{syst})×10^{-5}, corresponding to an upper limit of 4.0×10^{-5} at the 90% confidence level. Taking the total width of the D_{s}^{*+} [(0.070±0.028)  keV] predicted with the radiative D_{s}^{*+} decay from the lattice QCD calculation as input, the decay constant of the D_{s}^{*+} is determined to be f_{D_{s}^{*+}}=(214_{-46_{stat}}^{+61}±44_{syst})  MeV, corresponding to an upper limit of 354 MeV at the 90% confidence level.

[Analysis of the reentry status of blood donors with reactive bloodborne pathogen screening markers in Hangzhou City]

Objective: To explore the reentry rate of reactive blood donors in the bloodborne pathogen infection screening in Hangzhou City, and analyze the donation behavior of those who successfully returned. Methods: A retrospective analysis of the return data of blood donors with reactive bloodborne pathogen screening markers was conducted at Zhejiang Provincial Blood Center from June 2017 to May 2022. The reentry process for blood donors with reactive bloodborne pathogen screening markers in Hangzhou City is as follows: after the initial screening period of 6 months, donors can voluntarily apply for return to the blood center. Samples are collected and subjected to routine enzyme-linked immunosorbent assay (ELISA) screening for HBsAg, anti-HCV, HIV Ab/Ag, and anti-TP, as well as a single nucleic acid (HIV/HCV/HBV) test. For samples that show non-reactivity in both ELISA and nucleic acid tests, serum biomarker testing for the reasons of exclusion is performed using chemiluminescence immunoassay (CLIA), and those with non-reactivity are allowed to return. Results: A total of 4 583 reactive blood donors who met the criteria for re-entry applied for reentry, out of which 475 applications were received from donors in the Hangzhou area. Among these, 279 donors were successfully readmitted, resulting in a success rate of 58.74% (279/475). By the end of December 2021, out of the 174 donors who successfully returned, 114 donors chose to donate again. They collectively donated 39 530 ml of whole blood and 1 147.2 therapeutic doses of platelets. Among these, 21 donors once again showed reactivity for pathogen infection biomarkers, accounting for 18.42% (21/114). Conclusion: The reentry strategy has somewhat mitigated the attrition of blood donors. Nevertheless, there are instances where donors who were successfully readmitted show reactivity once more in the screening for pathogen infection biomarkers.

Effect of PD-L1 Expression for the PD-1/L1 Inhibitors on Non-small Cell Lung Cancer: A Meta-analysis Based on Randomised Controlled Trials

AIMS

As PD-L1 expression has been proposed as one of the cancer biomarkers for non-small cell lung cancer (NSCLC), the predictive value of tumour proportional score (TPS) in the effect of immunotherapy [programmed death protein-1/ligand 1 (PD-1/L1) inhibitors] for NSCLC is worth exploring further. Here, we aimed to summarise the outcomes of current NSCLC randomised controlled trials (RCTs) and explore the predictive value of TPS in clinical immunotherapy, including immune checkpoint inhibitors (ICIs) with or without chemotherapy.

MATERIALS AND METHODS

RCTs published by PubMed, Medline, Embase and Scopus before February 2023 comparing immunotherapy (PD-1/L1 with or without other therapy) versus a control group in advanced or metastatic NSCLC were included to assess the prognosis according to the patients' TPS with 1% and 50% as the thresholds. The primary endpoints were overall survival and progression-free survival.

RESULTS

In total, 28 RCTs containing 17 266 participants with advanced or metastatic NSCLC were included in this meta-analysis. Statistical results showed that compared with TPS <1%, ≥1% or within 1-49%, patients with TPS ≥50% benefited more significantly from the immunotherapy. A subgroup analysis showed that when TPS was <1%, ≥1% or within 1-49%, ICIs + chemotherapy had better efficacy than ICIs alone; PD-1 (such as pembrolizumab) inhibitors had better efficacy than PD-L1 inhibitors (such as atezolizumab).

CONCLUSION

The efficacy of immunotherapy (PD-1/L1 inhibitors) for advanced or metastatic NSCLC is influenced by TPS.

Predictive value of total ischaemic time and T1 mapping after emergency percutaneous coronary intervention in acute ST-segment elevation myocardial infarction

AIM

To investigate the predictive value of ischaemic time and cardiac magnetic resonance imaging (CMRI) T1 mapping in acute ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).

MATERIALS AND METHODS

A total of 127 patients with STEMI treated by primary PCI were studied. All patients underwent CMRI with native T1 and extracellular volume (ECV) measurement, 61 of whom also had 4-month follow-up data. The total ischaemic (symptom onset to balloon, S2B) time expressed in minutes was recorded. CMRI cine, T1 mapping, and late gadolinium enhancement (LGE) images were analysed to evaluate left ventricular (LV) function, T1 value, ECV, and myocardial infract (MI) scar characteristics, respectively. The correlation between S2B time and T1 mapping was evaluated. The predictive values of S2B time and T1 mapping for large final infarct size were estimated.

RESULTS

The incidence of microvascular obstruction (MVO) increased with the prolongation of ischaemia time. Regardless of MVO or not, ECV in myocardial infarction (ECVMI) was significantly correlated with S2B time (r=0.61, p<0.001), while native T1 in MI (T1MI) was not (r=-0.19, p=0.029). In the 4-month follow-up, native T1MI was improved (1385.1 ± 90.4 versus 1288.6 ± 74 ms, p<0.001). Furthermore, ECVMI was independently associated with final larger infarct size (AUC = 0.89, 95% confidence interval [CI] = 0.81-0.98, p<0.001) in multivariable regression analysis.

CONCLUSION

ECVMI was correlated with total ischaemic time and was an independent predictor of final larger infarct size.

Maintenance Therapy for Recurrent or Metastatic Cervical Cancer: A Multicenter, Cohort Study

PURPOSE/OBJECTIVE(S)

Maintenance therapy with alternative agents after chemotherapy was shown to improve the overall survival in some advanced cancers such as breast cancer, lung cancer, ovarian cancer and so on. However, maintenance therapy is not accepted as the standard treatment for recurrent/metastatic cervical cancer. Aim of this study is to elucidate the efficacy of maintenance therapy in cervical cancer and to explore the factors associated with the prognosis of recurrent or metastatic cervical cancer.

MATERIALS/METHODS

In this multicenter cohort study, we retrospectively collected patients with a diagnosis of either recurrent or stage IVB cervical cancer to receive first-line chemotherapy with or without maintenance therapy. Patients did not have disease progression with first-line chemotherapy and were divided into maintenance therapy group (Arm A) and conventional chemotherapy group (Arm B). Information on clinical characteristics, metastasis information, treatment outcome and survival of patients was collected using an electronic medical record system. The endpoints of the study were OS and PFS. Data were analyzed for general characteristics and survival using statistical software, and the results were considered statistically significant at P < 0.05.

RESULTS

Between January 2019 and July 2021, a total of 270 patients were enrolled from 6 institutions in China. 26 patients were excluded because of short treatment cycles (less than 3 cycles). Finally, a total of 66 patients in Arm A and 178 patients in Arm B were analyzed for survival. The addition of maintenance significantly prolonged overall survival. Overall survival at 3 year was 50.1% in Arm A and 27.8% in Arm B (median overall survival, ≥36 months vs. 22 months; P<0. 001). The median progression-free survival was 21 months in Arm A and 14 months in Arm B (P = 0.025). Univariate survival analysis showed that age, maintenance therapy, combined radiotherapy, and number of extra-pelvic metastases were associated with PFS. Further multifactorial analysis showed that maintenance therapy, combined radiotherapy, and number of extra-pelvic metastases were independent prognostic factors for patients with recurrent or metastatic cervical cancer.

CONCLUSION

The addition of maintenance therapy significantly prolonged overall survival as well as progression-free survival in patients with recurrent or metastatic cervical cancer and did not increase the incidence of serious adverse events. It is time to consider maintenance therapy as the standard treatment after conventional chemotherapy for recurrent or metastatic cervical cancer, rather than waiting for disease progression.

Lymphocyte Count Kinetics and the Effect of Different Radiotherapy Techniques on Radiation-Induced Lymphopenia in Patients with Breast Cancer Receiving Hypofractionated Postmastectomy Radiotherapy

PURPOSE/OBJECTIVE(S)

Radiation-induced lymphopenia (RIL) is associated with poor prognosis in solid tumors. This study aimed to describe the lymphocyte kinetics in patients with breast cancer receiving hypofractionated postmastectomy radiotherapy (RT) and to investigate the association of different RT techniques with RIL.

MATERIALS/METHODS

We assessed 607 patients who received hypofractionated postmastectomy RT for breast cancer in our prospective clinical database from 8 hospitals. All patients received irradiation to the chest wall and supraclavicular fossa. RT techniques included integrated RT with the photon-based intensity modulated techniques to irradiate all target volumes (integrated RT) and a hybrid approach combining photon irradiation to supraclavicular nodes and electron irradiation to the chest wall (hybrid RT). Peripheral lymphocyte counts (PLC) were tested prior to RT (baseline), weekly during RT, at 1, 2 weeks, 3, 6 months after RT, and then every 6 months. Grade 3+ RIL was defined as PLC nadir during RT of <0.5 ×103/ml. Mean PLC was compared by the t test. Univariate, multivariate, and propensity score matching (PSM) analyses were used to evaluate the effect of different RT techniques on grade 3+ RIL.

RESULTS

During RT, 121 (19.9%) of patients had grade 3+ RIL. The PLC started to recover at 1 week and reached baseline levels 1 year after RT. A greater proportion of the patients treated with the integrated RT (90/269, 33.5%) developed grade 3+ PLC compared with those receiving hybrid RT (31/338, 9.2%, P < 0.001). After conducting PSM, multivariate analyses showed lower baseline PLC (HR = 0.15, P<0.001) and RT technique (the integrated RT vs. hybrid RT, HR = 4.76, P<0.001) were independent risk factors for grade 3+ RIL. The PLC in patients receiving the integrated RT after RT were higher than that in those receiving hybrid RT (p<0.05).

CONCLUSION

RT technique affect the risk of and recovery from RIL, which may impact survival. Choosing appropriate RT technique to minimize RIL might be considered to benefit their outcomes.

Hybrid Immuno-RT for Bulky Tumors: Standard Fractionation with Partial Tumor SBRT

PURPOSE/OBJECTIVE(S)

Bulky tumors remain challenging to be treated. Stereotactic body radiation therapy (SBRT) is effective against radioresistant tumor cells and can induce immunogenic cell death (ICD) that leads to T-cell-mediated antitumor effects. Low-dose radiation (LDRT) can inflame the tumor microenvironment (TME) by recruiting T cells. We designed a novel radiotherapy technique (RT, ERT) whose dose distribution map resembles the "eclipse" by concurrently delivering LDRT to the whole tumor, meanwhile SBRT to only a part of the same tumor. This study examined the safety and efficacy of ERT to bulky lesions with PD-1 inhibitors in mice and patients.

MATERIALS/METHODS

In mice with CT26 colon or LLC1 lung bulky tumors (400 - 500 cm3), the whole tumor was irradiated by LDRT (2 Gy x 3), meanwhile the tumor center was irradiated by SBRT (10 Gy x 3); αPD-1 was given weekly. The dependence of therapeutic effects on CD8+ T cells was determined using depleting antibodies. Frequencies of CD8+ T cells and M1 macrophages (Mφ) were determined by flow cytometry. Multiplex Immunohistochemistry (mIHC) was applied to analyze the number and the location of CD8+ T cells and their subpopulations, as well as the phospho-eIF2α level (the ICD marker) of tumor cells in TME. Patients with advanced lung or liver bulky tumors who failed standard treatment or with oncologic emergencies were treated. Kaplan-Meier method was applied to estimate patients' progression-free survival (PFS) and overall survival (OS).

RESULTS

ERT/αPD-1 is superior to SBRT/αPD-1 or LDRT/αPD-1 in controlling bulky tumors in both mouse models in a CD8+ T-cell dependent manner. In the CT26 model, ERT/αPD-1 resulted in complete tumor regression in 3/11 mice and induced more CD8+ T cells and M1 Mφ in TME compared to other groups. mIHC analysis showed that ERT/αPD-1 induced higher bulk, stem-like (TCF1+ TIM3- PD-1+), and more differentiated (TCF1- TIM3+ PD-1+) CD8+ T cells infiltration into the tumor center and periphery compared to other groups. Compared to untreated or LDRT-treated tumor centers, tumor centers irradiated with ERT or SBRT showed elevated phospho-eIF2α accompanied by higher dendritic cell infiltration. In total, 39 advanced cancer patients were treated with ERT/αPD-1 or plus chemotherapy. Radiation-induced pneumonitis occurred in 1 of 26 patients receiving thoracic ERT. There were two cases of grade III toxicity associated with PD-1 inhibitors. No toxicity above grade III was observed. The objective response rate was 38.5%. The median PFS was 5.6 months and median OS was not reached at a median follow-up of 11.7 months.

CONCLUSION

ERT/αPD-1 showed superior efficacy in controlling bulky tumor in two mouse models. The hybrid immuno-RT (ERT) combing PD-1 inhibitors was safe and effective in patients with bulky tumors. Further clinical trials in combination with bioimaging to identify the optimal SBRT target region for the bulky tumor are warranted.